var title_f40_14_41184="Endomyocard fibrosis surg";
var content_f40_14_41184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Endomyocardial fibrosis surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 190px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Surface echocardiogram with left ventricular apical fibrosis and severe left and right atrial enlargement. B) Postoperative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Schneider U, Jenni R, Turina J, et al. Long term follow up of patients with endomyocardial fibrosis: effects of surgery. Heart 1998; 79:362. Copyright &copy;1998 BMJ Publishing Group.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41184=[""].join("\n");
var outline_f40_14_41184=null;
var title_f40_14_41185="Truncal rash in measles";
var content_f40_14_41185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57093%7EID%2F57803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57093%7EID%2F57803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Measles exanthem",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAUwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACinxxPK22NCx9hXRaboaFFedSSccHpUyko7lRg5bGBb28s7qsaFsntW5baU8aZERLD1IrqLHT40ACRY6A8dPetS3sFZlCozDOCzDNc86x1ww9tzGgtCjKgBCKucccCt61tYpLXEQ+TPG3jt61NBpsUb7ny5IwOevetFbNAcdI/wCIdj/n+lcsp3O2MFEyYEYl9q/eA3+vTio9KVUdwRtjf5if1/oK1TbtHERtLL93uDj/ADitA2lu4VG2bzGcADGP881m5HVBqEeVlK0UsrvIu4hiR3/H8a3BEioY15wCRk9D2/rVAW6LJG0qsuRlG7HHIz26461pWLLPu5XeOM45zWbdwcbaorQwg3YbZ91ckj6VPbvGz+W2PL37gSO3rmpsD7SIVmAyGLAAfz7VEizCYgIGUeq4wfWkappq5VlH73BPyjIQ+3+QKNkf2nyZFOCOAQfXj+prVhgkYbpgS+BgEdKfAqNM8z/MVYoBjkH/APWaLkc5mfZ44pxgZyuBnuc1Wnti+4fMCBlcY571t3cEaN5p3cAgDsM/Ss8OWLHYQQPr0Ge9NMI3tdGYI2Ck7QXz+lNaIOrggh8Y6/59a0nRpY1dk2u/zHj7v41C8BRdxXL5xuB7etVchptXM7ym8kDJBLDoRk88/pSOgLHeBtxnnvx71ZSLfOCWyF6FR1P1/SnyR4Ckcn0xmqMbamMBGZyoVRyACB6Z71J5ZG75RtPcfStFo1zyqg56454NOMSE/Nn1zmrUglboYbROHYMSBtGBkYzxULCQoSo6Y24PX/PNbzqhkMQXcp+bJH4VXkgRGJGeeqnpjtVKQb6W1OeFtKSTJEFHoKrTWableOLn7x4710kaZYgLwcbSeCecdPzqJoDIZMx7SOMgjHWrUyJQtozmXgyDhTk9hUFxaqRjZk9s+tdO1sMZALHGf61UktsvvdNpx69KtT1MvZXOba0BjPyEOOOPWs+Wywu5lf3rrHhByUycckioJovkU7R9elaKZnKl3OOktlJb5SPSs6W2k3fJGcY7V28lujEnHOKzZrVt52I2PyrSMzmnSZyNFFFanOFFFFABRRRQAUU5FLsFUZJrQt9Klk2FuFPsaTdhpN7Geqs5AUEk9hWpp+kvcOnmB+eSoFdBpmlrGoYIAAcnAOT7V0Wn2GFLbTyN23bzjNYzrW2OiFC+5gWukLE4KQgcY6da6K3slVANu4gdMdK07SyAlYsOnbb1q/DDHEoCjavUDOK5ZVGztjTS2Mq3hlZc+SEA9cfrV+1UuURdpz/dGMf41ZZd6/KpUg81KIfLhL5UOASaxcjqVJOOqI0t9jlC+4joMcirSWweBm58wHlc/wBKghu8ucwuzAZBPA/OrNuXkch+Xb+LH3fw71m2W6UlqLPADiNHyTnIGKZHDtuEWYEsBjIOPzI+laqrtuZI1GGbGT68VPFEhjlHlu5LfKy5OKV7Ap6WZSWESRCGbgDhG7j/AA7Hn6dqZbwm2Bk8v94BhlzgH/arTeIyOsLqMgDa457Zz7Vl3CSrICXJUOQjHgIR3+mOPxqTSF9iaOEiVZwmQ55bGcZ5x/n0rTjiCNv2hhjPYjHvS6OpYozSBjjBxyM//XGDitRB8mFAAzhsmlexlN8zM9bdxhed5GRuOTiqyQtg7QOZCGAXuO/5ituSOOXaHHIOQT6Vztlc3cmtz6e0MiW6gsswztY55HTr+PamtQUmxZhL5pjZC/UgH2qVbWMKSFAPpjOc8Vs29rtGThnY8N6dP/r1m60ki3ACll4BAORjnH9Kew1L2j5EVnt1kUp8v4cZ71QnhZFIC8Z2jJzWnLE72wMYIIPBArNuQ6yxAq+7GW468n9aoIxk1uV3tDbIu1SVzng9KrrNGsh6EHoOtbc1uzW4VZOAR09M81jzWjecyqpyOmQfyovYulCNRe8waNSXJwSvfGOTUTIrFFOdx5wO/wCNaKwLBb4dS+FA6VE+0wDy02sDwcZK81aZjyq9kUjCwbOw7cY3dPwqJU8wZdQDkgZOat+W6R+ZM27aO3+frS7d8YYfKTyDtz/nrT3J2KbWgMgIPA4yPzqFoN+4BjhjyVx1z04q+BHbRd2Pc9CaU/dJT5snHB6VSJk2zMMCg8k9MZHA6VUntmbJO4A8djxxzW1jbG3mdRkYxzVC3VJMsATCG4Vx7U0+oRjuzLez2RqItzZPzHAGfaobm2C5BwADjpxWzcKhbcnyN029N3sPyqvcx4XY6gL0BJ4NUpA9dGYM9uu4YPJHQCqzQfMdxIPsK2pYl6lAwUYAFU5YtjkHd+C1qpGTieUUUuOM9quwaXeTw+bFDuj9d4H9a7TyHoUaKtxWM0gkbAVI8biT0z0rUsdH+ZDKQSe1Jvl3HFc2xj29s0xABAz61tWWiIxBkfdnBxW9Z6dEuF7jrxWtbaecgrtHHIx1rCVXsdUMP3Mmz0mFVXaFweOmO1bcOnxpCjt91gfu1rR2IVMbfpnjHrVyCBY0yFyTgHBxXNKpc6oUtNChb6Yi5aTnHTnpWpZQox2EY2jjBqUWzFw4AC4ySTV+CIqEfJxjseDWTkaqFkVo40kYqByD3p9soklYHoB6ZrShjR+Tnpkc/wCfWleIYG1gjOPTPFRzXNYKzsynJCsZG1RvYdaZZwQ3JZWU4GOpzkelaUdlGcLI2+Rjk59O1WLiyXKtsVJACFOOf89Khs0TVrJ6lYWdtGnmBWAAyAOOPSnBo42V9m4suRkYx/nNWIrU3MCu8aYHGM+3HarsVtgK5xt7cdP8/TvSbBvl0e5FEglcbFAOM/NyPpVRZgrhPmL44P0rWjhPydTuJB9+uM0zyIJJGKKWdRjaSR9eakmFupQihkmGNyjORnqferhjSyiLyZcZ24Hce+aswweXNlnIj6hV7f54qzJaLOwjkQlMcEnJHpR0NOeN9djFg2xXXmwFo4pGUFPRj0I/GtAWwZhMoCsSGH0ODUwsLYQzRlCcDP8AnnrVRbqdFSBgOBt3epHGf0oKXvSvEvWNxHLKyKjBo2IJzxn/ACKIYwqOrchXOcDHX5v6/pVMErbkqG5OWOcVNpNwGuni/wCei7gec7hgH+lCZlUo2bkti6iZ+QAYAOc+2Pas/UI/Ntn+YhgvJ7evStm/VYI4gQRGy9QBngf/AKqo3vmRSLHABsYcse3pTFS6NGRaxGKGSRpGaLHCeh/yaj8giVZWfcJQRtwBgDkfWtu0QToybFV1698Ln6e1Q33kw7Q2cLxgcD37f5xVD5m5NGZaZu49wO0DnkA/p26VUm8yGRsldvYAVqqIpEkaNRtI6BdvTt/Oq+n27SowB4BwARkUDXKru2hj307rlePLGdw9fWmQRpLbq8PyZPPAHetieweKZxsWQE8k44+n6VE1vswqLsdgSSMYX3qkU5QskjPkVC/lEZBHOR1pILRISUj9Sf5Vde2+ZVBwyD5j2+v6054xBHuOBH3x3/ziq23OdvojOmt45onwMYGPp0P86zHMiIkhYHADEnkkD/8AXW5IkgGIwu0jOfWqiAMHjkJJAy3uD34+lFzSDstdSusSszgqMj1PuSKbLbsY2LFGx061eESbAQML1wOKZIgPICg8U0ZPQxmgEy7Sq5DYJ+npVW6VHBjZRvXO7HAbHWtecN5oGCFJ25B9e/61l3Bg86M/vWJPOT2qkzWCbKjQ5xswFChiPaq8sMitw64IBHy//XrTMKsdyfdI+UHt+o96rSxhXPybvx6VSZn1OX8I+CIr63+1XhYQsfkQHG73zXR3WnrkQR/eICqmSSa7SGyis7GCKJEjVVwFX+f86wtWjW2t7u9CsvkRFUc5++Rhf1YV66tFXPlJTdWVjzvV4ITOtnaN5kanzHkByGbHAH0Bq3Y6cTtPTgjOaZpltkk4yexPP1zXSWNqcqSMJ7jrXBVqXZ7dCiqcSK3sFjUO0ecju2K07e28uPYOSec+tSwQ4z5uGjA4GMn8avLEMYCtuA7jvmuWTOyMe5HFbs7EbcL7mrq2v3dpGenfmp4k8sruXtn5hVsIu0hQS2Mj2NQ2VbTQqx25GCQTj+7/ACq1DF8u5gR14NSxKEA3sq59BVoRLMR5J5A5yQARipbBELRkYKEOwGdqnOKdKscjCRx84HIDY96mljaEIY0O5uDtq1Dabo8SRjdj0pXNIrTmIrWPzo3ZGJyc5Az71XVpEnWAoWznBx049vrWhCqWcYRATuwQDz+VPt0D3KMYgj4OdwIx6VO5cUk22tOhUtPOik8kx5UsfmFaDRMWT1x25OP8gVMIx9owI2Ck4HtVoRyMN0aKB2JAB/CgiT10KEVtKZWdhhR0IByakWzETrIqklgQTg4Gexq/DHMqjeD8o6Ducf56VLDm4LxpEyqoz83HP50tyLyRiRQiKZ0ZjhjnHda0ViZk2r83GNx/h/LvzUsdinnb5OZDnCs33j3qS0guEdslQu3v0Lev/wBelY0nK5lSb7W48tssG4zjHGOn6VLd6X5wBVSDkKGJ6HHp/nrV26t2a6j8xMtwTx29akuVdFMglOAchc8E9v1xQPmas4mHeW0kEJQxuV4xjB45xVewtzbzpdRqFEbEuSff3/E1siQ3PywkO20HBI6UW9v5sEsKmMljggjt37e/8qa1L9o1GzJL+2N3CDCAZdxIRjye/wDSp1sHECmR0DLktjnNRtILSMFJN7pgqx5AODwT/j61ZspjcFfM3EZ5AH88cVSscsudR8irHa7BM2Mnu38vaqV9Ym5hyTtbuMg8VrDzGlkXAWE/dBGOff8AWocMzPjbtxtyBx1/wpsUZOL5k9TDls4orNgd3Ixj/P8AjUMTxwT4yWDKMA8EH0/WpdQFwz7QxA6sGODjjtU0dqs1vE8yLu45BAz/AF7Ujou1G0nuMeLzSwfBHAODiqV1F5cgWBMqPmPOcY/z/OrDXTG68pkClzxxjj1//XTLvzEuEEYHzcP34/z/ADq0ZK8XqU40Ub1zmbBLZB547VXfcw/eDGOwOcY4rTCrvYyAKQOdowcenPtVbEbjJ3YxyQvWmTza3MpHmY7jgxrxnpj/ADmpRGHU5bjGQasY3OY2jCjOSFAA6cUs0TREbU+TGQSD7U0i6kuiKD7S23lu5FQMo3kgHOOT7f5NW7hAUZo8CQgcrx3qFlZPlyd3f6UWEyozb1dD0YFd2Oh/z/KssWi4UFtxGSMd/wD9YrSvJBbhCR8rFs4GT9R2qs8b7VKKV+X14P8AWhFpuKuupSuEnRd0Ua7F7Ht3z1qMDzfmckH0H/6q0WyIwGBPHzAc81U3omA2AfTFUTzN7bnYSIrRx9HbbkZGMD8K4rxrd+VYR2isCZiJXHPqwx6dhXf6igWHncNvK+5Ary/xrcM/iIwucLBHGgGOnygn9Sa9KrJqOh83gKftKnoUNGhAQs/K5+Uf410drHmJT0Xsc1j6aA0gVQQAeM10dtHtweeefpxXnzep9AoomgiBXLDOPyNXreIuRgY4zknmoRAZFXykUnsSSABV2ztmhYtINxbgeoz7Vk2apK1yaOLfKgc5xxVr7OrHy1fDdOM5NFuqwb2Z+p6Ac5qyqsI8F1ZemMf1qWRdoDbROApGSMe2P881NbW0SSAncmCV9QeM8/hToEwMMFXPHBzgVI9vIs8ZiIKsMMOvHsf1pDi/s3FKKrL5hIywB74+lWYUDNgMxOcDHHf/ABpZIPN2kSbivzAL0zjvU/kMImaGUbi2CD2H060CujPuYZLi6xGFjZAOfatJbYL+9UGSboVJx7Uttk3Ikdm2hVBAA2k+oP8AnrUt8Jhv2jk/xt0/L/Claxo5OVooS7XymWRUHBAxnqP5VYkGIfuFCo7HIHIx+lQiCYiF5/LY7sNtJOevTFbEbxLGwQBiOACcdDjrSZnK0bdTNtZZJ1O6MLs53A9c596vW8KYdU+VixKkMSfbOR+lNtbaa2llaQhYwQwBH3asLyseZFBCj5Rz2x1qSZtX93YrsqZTzFAkHQ9c+/tn0pn2mEiNdpUMdmV9uf8AP1rUALgK+7OSucdKzrPT44PP8hmbcSArdD+I+tGoRlFrUW62L5bHOSuMn0x/gM1RvmRiIQOJflUk/dOT/hUrxzQXXzxfupMI4z93tkeoPFS+UEjOCo2EkBgemf8AA9KDZWjZmHotnKZZXeQKF+QlOK0bW0+z3LsJgTgkqQeOmP5/yqlDJLb3MjRhAshPQ5PX0NW7M72aaUONw8tkOAQT/Ugj86ZdRt3bLEttDK8mExk8qenJ6/59KfAiWkDs7euQox2/+vSzzAbJHGTt6L375/Hgde/aqmxLqwcSqFCjqG4HOT+mKZla612LcSi6j3J/Ecbh0zyOh+hqCPyR58e5maMlX4x81ULC8CvHCQSpYLu4xkY/+vV1ViaaVYwxLOCQD9Mn/wCt700TKnyuzOfut1zcZ3MAcDeP4unGK1YLciKNZiGCqCOMcfhVl7BViOGKqeGBHJ57c1DcQCWEI7fIAcY657fh1oRc5xnZLRFDyLa5uC+W8xQuRjp3z/k9qS5jhQljk7cfNznrUISO3kcow/eLnJyMDtx/n9aUOssflF8hvTj19RVpkTi0730IrrasLSYBbrn1qlKSlurqNqnOAfQ+uK0ZYVEKJKxYouCwx0FZaXjT3LxTJtJ6D0FMUI3u10KsMkjSES4LsOMfXFPmufM2RmRj2A6c4qzd+Z5OFXP45qo8TxoBjGOcZFNMt2lqJsGCpGW7Y4GKrOpViWbOemKtPJm2BAwxHzA8VWaQNLjKt2OD0oFZ6lW5hSdSsgHTjHBqoJUMrxo5LKe4zjmtCYSCQA7DH+oqrIgWV5Ng3EYyG6/0FO47aalZwzluMAjG7OP0qk0ScAuxK8EkAmr8jmMs3ONu7GP8/nVaIK8asGODzyMZzzTTE7pXR3l+hJjJ5DH5cev6147r2J/E2oN0BuZOnP8AEa9tZJHvoBuKJuycc8AivCnBa6nKqxLO3HcZrurvRI8TKY+9J+hr6RFh3dmG0j0/Cugt0yoyDtJ4xWNpSbo0PTGTnGc+nHfvV/TTN9pG/IOORzXBJ6nvKF7+RtQ3KxlUIIYZ6itGLEiq6AlW6YqktrH5nmSOFXGMnGK0YmjjieQ4ZFXG3OeKm76kNRfw7jo1wjbeh6//AFquO6YClxuTtjrn0qnat57IRhQMHI4JH+f51a1CWURMqKojIAHuOM8Ur9QVN3SLcGZVhdMEDgEH8efyq1MxJjUkAdXJHTjHFN02LfZwvGSzryygeuTipdjNI2EPDcjHTjJP86LGbaUrdiQrsQZyF28k4/xpZsRFl2sxYb2284oLRLw4VUYhfuHj3FTSYePbbk8NjO7IP8s9vypMI77EtlKkymIrIrBgQfUDn+tPuo2uoMJ88uDhV/r/AJ9aqKGS/DR8wDhz/dIx/T8/wNamPMcxkBg6kBj1Jx6fpSB+7K6MuUyw21vFEoaNdu4dW569D7+lbVjbCW1ZXLLufLA8HOO3tUFoWES2ykhPvK2CcVauTP8AYsQws0gwcZ68kcj8Kkc5OWiHzN9oVrUEEqBggEA8c/5//XUmZAIQwAVcNz1JxjH61Ws4R5V1J5pnmZQXBGCO27npnrU7KWRXSQltp2g9s44x/npQZS00HrOVxGcKMAfMPz9qeXVosneuJFblf4eef51FIZDEpCs7MrEq3PHp7d8UWsj3MEirkYxtweD/APro6Ct1KWq3EUU6sjBnKnAPHpUFhciRDI44PzEjgdgR396luosMHMSF484yBknPOT6VQiFy958kTLbBclgDw2McCjY6kk46EMNmwtp/MDNvIYBcAnJHT8qs25Vr4pM6KGO4YPT6/rV5XUSo6/u2ZeEBxjucfyxVWGDNwS65USDGeeAM8/pTE6jle47VcRKDH84OTjuRkHH6VjedMizN5S4QbdueeRz/ADrW1sedbK7rs8sBjg4wB/SqHym2MWQjsSWUHnAx/hQjSlbkKEkoad5JiAJQQ2O3v+laVvdxJbxYPyJjBweemO30qCSwxAzgbd4+XaAORwQPT61nz71kjiOVYLt5bPXgfzoWhs1GqtzfMwkgZJPkDDAJB55zx+VQkD7E8e0guhXJI6YH+NZCW6Qyxv5snykkAggHg1oRXccxfDYBGMA4B7Y/z600c8oOOsdjKv7jyWiRlJ2JtyOQc8fh0qO3vY1UtkgqRjI4/wA8mor6GVbYRMdwwckH5gM1mwRhLhEIzz35yKd3c6PZwlHQ6BZC5LqpzjBP8NZtyuLjf94nOMcU+6u3tgEjhV0JJDNxk8j+lRJI1wkmR1Pb8O34VVzlUXHUe0xcFdpzj06VXSRhlyACBgVHbLOo2sMH7wOaimmV0AjYOwbBwc49R+HWnoHK72RO6ZOeM+oNVtp3sV5Lc/lirjkLCq4GWHJP9KqyfKy4GWxk8e9AouxlahJIzOCqAKSud3fH+BqtHOJ5AsjKip/+qtC+jeVHRQSWOePwplvEIWZyp3SDLBuef8mkk7nRKceTbUiuYxPGgBOE+6QMg+9VXuLeEiOSZQygDrVud1yysoClTgnnn0x9KxbnTYbtxJdSSJIBjAI59+lUjJJNWlsenTS+THcSSSBNlu77h1IAyQD2PvXi1sMzsSMZY8mvVvEc23S7py5iDwsg+UHJKt8v6dq8nslZyCzE88471113qePlcbQb7nSWvXIwAT2rWjBKt5bYKn5mIwP89KxtOyud5PHODW3bKTGRkFWOT71xM9dNInleZxtUOQO4NaOjW/7t1kXeDgY/OqsHLkGN9uOvY1rWTeVC4A5556EH/wCtzUpalyq2p8qJ7WERRshVeWyeMcelXkt4ZEUMUJGdpI/ziqyvvQ4KhmfIPBwKuRIEVsNwf/HaNbnO5depZhEgjwSACcgZ/iH/AOv+tKgfe5dMnABPHHOev51DbO7M+/CiL5mJO7j2/wA9vrU5lUrJ5e/YwDD5eWwPTt/Kk7it5FXUZNrqUt3yWILbTwT9Rgnr0qzYSrLDM4Xagfcozu2gZ/Tms6+vXmHlsxVgSQQOCw59PY/nVjQY28yaJm3J5ZyCduOcdO/TpSudDppU9SRr3zFk8tsFSN3rjjI/pUVnetHqFutyZHiVskZOWGRxjr3xVmKyBmdItqM2WJIyCAc9T7j/AD0pkNixKG4lieROSyrjvnr+A/KizbDmpKL8zdDJ5pznC8kk9vxqferA+WFXAxlupyc8dz2qjHIfOaPAKsCSSo/n1x/nFTmFpJYisgjQDJxzz/PHWh6HHp1NBLmNRIeQxGQrAA9D754JFRXMh8ltu1CCCAOme31qLbtLuMSSN9zcOvOTxz/hVLTzcSySrdYKFiUAOcAdB/nmkkNRVnInN0Ps5kkLllHzYQ9j7e1WbUKwGDkuqj5hzgHOPpzR9nQxOjBewYAkY/yPWonuFjmSPjdt+UDA/l/L2pkt30iPurYO5DgOCNpPZefTpTFljQBCvyqQOPl9OPyqC4vGSdItsjb1JGw55zjn8ar3UmJlcOGV+do9Oef0+tCNOV9SRGkiG58yuQPlA2kfWn3M22NJIx2xnd24PP4cUyAkzIZWLKRtLE4Bx/kVFNcRbI18vdGDtPYdMfj1zQFtdhbnfLZlod0shOSucE9Dj88VkWVjPGVSVwGAzzxv6+nQCtFJltpY0DvI8mMoB0z/AC6VY1PapYkr5mACU9M9vz5p2NY1JR93uMgbfHuDsUDAlQc/19c/zrL1ea3aUJnleTgnAxzg478j86vp+6TP3VI5UDr71hajFvu38tc55wOufUjv1FD7FUEuZtlHDMrMcLJjp97FW7C3MkjT5TA+Vst0745qzHZJGTLJtKoNzfN29xTEgdYSUcFcFvk/jJ//AFUJG86yeiEuVMsLtG2ZQWCjkEcjr6ccVmhZYZFMy7pD0AGR+oq5aLIqGSZnDsw6jHP41NPtIDyYLL0GRmqRhKfI3FaoqllI2MyhQOMjNQB0S6ZfmVRn+Ej8ajmkMdz5Zj37u+MYyelSSsN7FsFux4qvIzatuNbZkHaAh6rgZqmkJilOwKpz7dastIJWPlEYz6CkkJd1+6Fx1HrRYItrQgmmCELI20D1Y4GP0qpPMdxfkp2UcZ7U3UkkuZMRsqDoec/Wl8kqzebll68Dp/nil1Nkoxj5jWJKAhSpIzg9qiPyx7pGHyjLce1TNuLYByMccVXkZW3LzkHkEdf8adjMgZldQ6kFWJxx1qrO8SSYdVBxViRdg4ACKCcf56d6oXksCTlZPvfnTKhHmdkdR4qcQaLNtb7zJH8p7bJK8u0pW3ndkEsevUf55r0bxy7R6Q/l42Gce/ARsfTvXn9pvMOU5fBzjHWuqu/ePNy1Wpep0Gnv5yyuhwvAXd61txFhCg5LKvNZFmuyIEcMDWvEpYYKjaVBP14rjbPR0NKCRfsyGTrgdRWhakglQevQA/0/Cs6NmEQHHHTJ6VoQxtheORhuv51BLsX49oQjjPY461JNEzIQAVfsG9arxsSJdxwgVSpx35/+tVizZnSEui5JPzBeTz+tArW1NCORRNKhBCjLRn8sDPr1qyPmjTedxwS/Ocj/ACao3KIdyIzAfw9v89Ks2+yG2ijckllbGee/bHbk/nRuZ2VrrcJIXkjLqXI/iJDdSDgfjVOyuYluZkhZvLIzzk/MPrz1J/Ordy5t4S7LhmbZyMgqQc/0qqjWyXRcsoVh82Bn5h29fX8qRvFXi7mkwQwT5ZQCxKZOMDsMfhWdpmWnSRXBUA7mJ9wO/wCNT3bNHaytufZjdnHQnnGMdBnj+tU7mEzRjy3l2gj7pxx3oYU1eOvU3ri5hgt2ZiQ4/j9OeDmnwSs5QBgS6/N6N7/mKz5E82zxt3OBwv8Ae44+tPCbSpdURMY+8Bg4+vFPyMOVWNZ5ljj+TJfJxgd+eR+NTTPGsxcOv2cHcOd2FJ4Ge30rPtrh5UUueFGRge3pVu2Kvaq0o2rwWHPXAxnPPU0jNqxLNKjRMLdW3NwpHTP+SKpskO9HjRlkGSGJJxn3zVVd0MbxrkE5wD6//rq7bBUZWOOmRuHcdc/pRYv4dim6OJXeTLv2O7P+e9Z2qTeTNGxLFFdckHOeMfyrUklMk7qgG4uDtUcAZGSPzP5VnXAWZ3LAOMYHvg07G1OajK8kRQ3OWSOSTfn5uOex5qS9AZYGiXcoycjHo365/wA+tBrbziV2g8/wtx346/SptRB+xRJHjJYZUY44PT8cUjR8vMrFuW8ia9iRCQPL9OMVLcSLmNMYHI2kdaw7Nw14yKBiIfJkYHBwK2bsQz3KbDujT7relNEVEotISS5idXYsqjlOeMnt+FYtzciOWUGXBxwB6Y46damuyttkJje2dxbvj/JrKZgZt+FwSc7fTvwPxob1NqNNasdFMJJ1TdwD/FyOh/xro4QscQVgAMKAPTj/APVWTbQwK2QoVsj5tv8AXFTJN5k04fAAJ28YyB3/AJUIzrS53p0KgeZBOJpgTuyoB+ox/wDWp0Lu0aFiR83zA9x+FSXwIt2MSKzLjjrk1Dp7vNERcr5YVsYUYHaqREndOViZJY2yhILdSKpOscZIKjPXHWpJcxyMYwATkEng9M/4VUifeD5p+bJ5I/z701YmztdA5iTLnAA5LY4HFBbzLd2Xl+x9OKSdt0TEKC54I5ORTSkYUYODjt+FO41Zoqt8qgsMMe+On1pZDkjeSW7571JMisD6nHPoc/4YqNgQmT97vzTQMgK5ZnUY5xyOetQTsN2OrbuPUf5FWs/K3vwao7wbiSPoFxggetDHG7+RHOSC23GSMDJHB/Gs++lVZgMZ49v61fu1V4yJMgD5gVFcrq1tLLcI67jlOoA55NNa7lxWlzp/iC3/ABKoS0YIMp5DfdO04yO+eevp71yumMcoxYA/nXVePCg0tN25czNtU5+YBevPPGf1rkNLIzHkZXpXTXWrPNwT/co6SD7gBxu7jNa9tKDMq46jOcYxxWLanOC6kevrWrDy52jKqSFI7+nNcbR3LzNG2klbKyDaRnBAzxmtS1XyoAJHLHPXGeKx/MdcEDoMZHer8MrFQrHHTB65B61PkOV3qaMcm+NgCN2MZX8KsRPtQW+8SADG4sM/lWaku1cgDg8gcZ6VYQbWMhUsFIyeQRn3/wAaLEX01NO2fMrBWVlQ44wcY5HH9KnMxE6luFIwT+HYD0zVOBRGshgKs5wDg4zkdfr9akVtpUzYAPQHn2P580PUhbk98BcJh0APOMHG7P8AKohHHb24nU/fUEBznI5/wqxaz288qx71fcM4HJHFVWnUPHHKFCKMKHTI68Afr+dKxtGUkuVlxJori2UT7Q5XlScbvf06H9OvNJbRyQNHExAJz823JPcnA6YFM8qCSQMOiDaw3HgE46fT0pzlkkErOwB+71OPXnuKTJUlstikLmVb6UJycEhcdsf55q1NMs1ssBG9ycmPOcH0x7cimukbRyNbR/vwPvhs445HvVPQknk1HdKNvykhjzk9/wCtBv7sk57WNPSmuEWUXIUKgACuOhzz1P4/5xVmDVNzFIXWXaoP3uB25/SmT70Z0OG3cfdwSTzVHSYIPPaIhl5wSASSPX8xT2MrRmnJm2u2WMNKQvzA56lQcc8dKindo4y2SFC5z/hVR52keSPcFUDaAh69epHofWox58sXlyMTu7g52jsOv149qfQzjGz1K8eoGSeYPsEYG1XAweT1/QU9LlFWInaGxjB5JPrnvUJt4o7sRHBJG7JGOe9V7iLbKsjlhHDxjOASM4P5UkjdqDehckkyCI28rJ3FgOue9MmCxJI0jgqCDyO/FJMd3y7Rg456Yxn/ABqlLcCYSQyDgsRnOCOB2/Om9CaceZluGOI/NDIQSM7h1PTikhkl/eCOQlCAQcjGf8isuyuGinWIyEcnJYcfT9BWszbJE8iLMQPOBjjg9MepNF7hUi4Oxj6pJcIx81iSBgDBHHbB9Pak0tzh2KgM3B3HO3I61JrkizTiNTjrk1SKzRRo0Ss4PGemQB1/T9anqdUZKVOz0NyOCOE7ogGVQTknI/z9KoTzTTSoQuEOMntj6Vat5XjiQTDJf5cYyOvtQoCpllGSdpUDgZ7f/Xqt9jljLld2rjxKGTYSNm3khue/GPwqMFMhFb5B1yD9eaqwKEkl+cjJyuTuAHtU7Z25+UZ5Ldj+FUjNpJ2QqEsSImyhPUelUo4htBQMdxxtxmrcRG3qIwPQ9BVeOUEtklFViPl/Q/qae4K6uVrpjHsCIfmzz6cZ/pVeOVJGIZgcDlgOhq28iywFuBjoc4x+dUIlELMDg7v9npQzWFuWz3HDO/5SuwjH0qOIFIjvfcfcVAs0i3bqq5jB5OOnfpUck52CRZP3ak7gV7YFJM0cHsWpCRtcEkEfgKrSrH8zDGeO33qkjlSaMGNgydeD/n3qH5v4hjA454P4VSWpiyFTkHpkEjArmdZM/wBrBimkRSoOBMB3NdHK5RzhRzzgfzrB1DaLjbJA52qApznI/L61SYXXVXNjxwVGlW53rt85xtOOpUYwe/euPsHIlAkGQRk4GARx+tdX48L/ANkwybgwW4KsSPmBK9AfTj9BXIWEg3KvOetdVb4mefgf4SOotJRITyT35GK0kJRAN23Bz9KxrWRfLwQ2RznPJ6VpRtgAN83GOe9cb0O+O5tISVCjcSOnerMDEuoz8oB9/asuKUBRtzwOM/WtKKUiQBgMgc4HXr/hUbDa6GhAwUsAu7I5HXr7VKr5eMkPhD1xiqCybXOScY3YxnirbvjKEkjkMDjml6EWfUv2knXePmJIRvQelLe9IllLYDc4XnBGR/MVSlc+UEBwp6Hv1p0LuXQ7ztiH+cU7BFWdxbSGRLsY3c5x8natCzlLvKZIyCrnJPpx2/M/jTTKIlEgjTdg5OOTkUiSzKjNEVYYLHf6fh9KLFyk56j53C4Y7cq3U/LxgcfjV6ZhNFJI5DGRT0bPT1P8hWZIvn2zoTgdeB6VaigYBlLDj5iw6kdP61JMrWXcLSB7ZTIgyvXIz169adb3A82YMEXb6kHv6H8Ke0jwAgnK4zt7AEZ4/A01mKeVu5Rl5AwDxn2+lOwubm3I4BPLIXMuwMVIJ+XA7/nRI32e43BHcumRsz8ueuf89qnJMNmJFYknIyRz1xUVvM8ofzCNw6YUce360rWKU2030GpblrgS5OFOQqjpkc/X/wCtV2Rt4d8PkjgEdB7e1Vo0SOIRrkAlvw7/ANaqSXwjlCqnTK/mD/hVC96o/QlluVgjDSKSwJ4HU+9V4nW5BLAtwfmxxnPrVbVJme2dsDIXn6cfrUOmP5UZY5OAW69TS2eptye5zLc0zO6LHu5z6DnGOKjRQ+QRll4zjr3/AMRSbxKWYZARiP8AIpt6+Iiqk7uck9yKe5klZ8vUS7Ee+N1TevQ7eo4NQalLJFIvl7kQjJUk4z25qpBM9u+FdiCdxzWjdRCeQb8HA9Kk0b5GuqK1wnmWaTEEtkDg89+aFkA8mMoSOM5Gf8/Wq888iSpENuzcAOM9Kf8AalBaN0DFSD04oLcXy66k9/JJFGjIGbJ555A9qqXrTFVmWQqCOhPP51bgw+SoPHUHp+FSSYaEs2Tg7fc/rTSuZqfJ0GoxkgHO1guSM8t/nmlLDyFQZBPPzfU/l0qC43CMhNq5OCev+elQLM0ShXO/nIyOlUnYy5U1clldmnZs/JnC/wD66bOc7kLDdnPXpVditwfnUbxyrd6QkNdFFyGVMkjvzTuVYewP+7ngDHQ1AEUOHJ3HGf8AJpiuyplCcHrk/hTJOoHoehoGk0yU4GTuX0+tVL0qkMhcEjbggcf561ZIDKwI4qnPgQugH3gQM80WCG5X06KKK3byl2pIS5DHuTzVa5eR7qbYzhMY24znoKksXCrIndWJP4f5NK6rGzOQ25sZOfWhGrfLJ33IIo2QHdgEj05+lct4nvTaaiiYJzGG4Pua62U7QCADuHGa5XxAJjeqYBEV2DPmKCc5PTIPFaQsnqZO8ndG94uLrpXIDBZ2G4cYyvQj19Dj/wCvyGnzblBB+YHNdR4vJTS3yjBTMh4IIGUfr3B4rjbGdW2oQc54Pr3+ldlZe8eZgn+7R01jMN+DzkY6dea2IZASAB1GQfauds5gpbYRgj1zWvFcI21j97pt79a4pLU9BG3ZMDlc4Y+1SxMfM2l+BnjHT/OazUkUEDG4+561YgdQ25j8w5rOxcX1NWNQZGzgtwv1GanEIMpdZZ1kzkqJWC+3AOKoRzKXG3kjkn0qwJSAhAGR696Vguy7bzrkIrHcAOT/AJ9qvK5KZ4zgnI7+9YNsFS7Lb+W5x6f5xWsrnGUOcgHpxxS6hNJbFjzZZjLG+0jqB9D0qUzj/l5Gxfuoo5785/Gq6OCQzgdjgZpzAyhs7AVOBk46+nrTJXmXLKZJ4XBj2qoJz3qWNtnzBvlOOoP+NULM/Z0IY/vG6/MORVpJR5wYMADzgHngc9R/SkElq7bFwMqW+4Fslu/Xn9Kpl/l3Byxxgbien4CkeWCQt8yFy/Tcc/5zTGKspMvRP4l9SeOuO1AkrbiXM48/yyB1HTrx0PSrEl0I4SzkjB+XAx271lPOblQ20ZTlcdDx0HrUtwWNsFUDjBPOfrQjZxjdJmmtwoUOzYDcEY7n/wDXWdqAWMqLQbXJ3ZP9KjVQ7pMx2lSMrnPf16VR1O8jgyiKQpJJycnvQyqMPf0HX87+UqkLnOWbGcmktZwjAoSxP3ieOOtZ7XbSRADBVR02nOP/ANdS2u2RST98k9+5/wD10t2dE4pRtI3VlDBxGAGY9SMdP/11Tvb0q4HzKBg8YzUbTx2aIScsBk9vasrUGSaRmQFWPByOo54pswowvK72LkM6TsA4yp4Htjmrcc5NyEG7rxk57VlWrnaHcj5O/UnNTRXhW4GBuyRgjtSNKkb3saBSNmVm+UDrgn1709/KcFTt8skAZH0/wqrOyGPywWG8bQOM0y3mVGVRnKEgE+1Mws2rhcyiOILGXw5A+8ajiu2SSSMgt6nOcdPWrdxCQp3YJ7kcfpVGAlZ3GSMDHOACaC4STi7mg00ssUXz4C5LY71WllDMUGC68gsOhpZWLRbIQASOM1BGrQfNLjeecjtVWM01uW4SwRdx3NjGT+VQhwshcgH0FQSzb5AqthgMkEdRTnmZIRsUE5yMn/DNMhxt8yQyk7t3OPaqg+0LcZfDKR7cHNMS4Dk7w0e0fx4H+e1OkkQZA600PWOgssnzhgpx1wO9Qw4ThRwB0qNtwLMGGwdj1/CnZG7+meaaFsDRgybhhQeTjv659arn95vUDCj5ev4fzqVmDPhSCR23cioMlTICd2fw/wD10WG27FOeWWKdYwylem2uS8Vx3c2pqbeGKVRGAWPHOTxya6u5ZlkPQKV2ksDXC+KruWLUlVR1jBPGecmtKad9CarVrs7bxWyvpE2S6N5icEfKflfHXPNcHZPgKT1z0HpXfaqGmtb6J2QN5JmCSJuxgN09DzXm1tc7SSc5XnpwB9K7qy1PJwT92x0dk4XKk85zWzCCilwUIwCTjp07/lXPWDhjnIJJyOvbtWxBOQgQnKg5K4xmuKcT1FI2YC5x5mOB2yKsJJgjP3u9Zq3BLjnah5JHJHHT86uFwo3EZHHNZNApa6l+JmEm84Cn72Pep1uQJtrsuO35VSV/l696lVU3bpFyTgrxU2NE11LkUsT3RCtnA4x/n61qQudoySOMAA9R/nNYkax27+YF5x+tXoLnzItykj09c0rDmrq8dkaEs4ji3Zz6e1SB3kBcNjdgr0GP88VRA3rtJLY6g9PpUrXAhiRpM4PTFGwkrllWb7WDLwgGB9cfy/8Ar1cR2ClnCkgEK2OueufbFZqXK3WQgK7ep+vNTtI8nCNlP72e30xSQTT0voV7sCGUHzGBzkjP4/zq9DJ9og5O1WOSBxjr1z9KrzxJK+XHJHOeaejLDkR8g8/MKLFSleK7iWsbKihsgdAG46df5VLcTfuiEX5wdoAHbIzRLLGykgcjG1efx5qt5jqVBAZ3OAfehE3bd2ETuFRCdvzH7x6gH9aqXls00x3BdpBOSeefSrQcMUcDIHTP+c1FNMSSCV+UY6c07IqM5RlcyHgnVnSPooC5HAxn+dTWZYMrkYPPy9B9at3DGO1bYvzsMk/hVaMkxp6kdfY1KVjolVc46iaqZZXCooKHqTwf89KqnDSKdzNzyN3T/PNT3ZkaEeWCz5yecCqxDwRRuVXIbnv/AF560FQl7ti1PLHBC6EbdwwD6ntiqgmO8mN9uOm7GR+VR3cwuj8q/JGcZz1NVoyqqzscnsDzQ9zSmly2e50G8Fbd3PI6/lUTSB5HMZG5STg9PrgVnxSs8DEu25ORzwKnsWJZtzDLLwQOT6/zpmLXKmzW89ihaRjubjrWRqUV5JKjW8ioAPmIOOatebuCbckZ60vmoyA9n45p2OeL5XexOkm23VmI3eueB3qKa5B8ssybScElvr71BGFVChdnH+12zTJolkTy8ZAPbiqFZJjvPikJaM/P0Oeo/KnLIjR/I/zAnIOeKzQDahmJzGTjJ689qlmkfaHtdjD+LIxn39aE7FSgm9BAX88W0vzqehPXHXr9afHMsmQCBIOx7/SoYZy4WWVNsvbBzTIthnMhyrgHge//AOqgcmtU+hbLjgAkj6daSZkVd75+UHBGarPKVwduU9Qf6UwyuZChAKYzhuT9aaM7bD4WQSmRS3zdPp+PNUhO0UsxkZ225xnv9KluH25xlGUEjgYxmqkisd7SkksO3T3ppFqXViRXDz+b5gBBztB6+1cP4qmk/tMCFVddg5IU85P96uxEiBiEzuXFcP4tAbUkMccmPKGdrY7n3ranuYV37rsejzPzcQyKh327KgLEF2IAwD/WvLo32uQThQeRXo/mrDcWwKsUMijqOBn1/OvM7xSl9LEw2srkEHqDmu6qjxsLLzN+0lDDccYzjitZGDsNp56jjNc3p7eXEoxnBrYtJvnBI55HFcckepCRsRO23+EBh1q1HMSSzAgZB+Xnn/OazFcFQQcHvkVbhlXIYHIU9ueayaNkakMgKjb90HHSr0bFSCMbulZhmUx8kDIAGOfpViGQLEAOQoCj1/8ArVlYa2LV0/mQ9Rhefwqzp8v7gBWDN/TiqJAkiKeoxUtgRaR4Y5APXFLqappwsbCctljng9BU0n76EBuxzu/z+NZgvYnmWPnk8H8avQkBMZ+UHFG5LUoasdBH9kC7QzZxkD69f1rSjmfcS6HnqRg1ntcJIfMXIP3cEUFtuVAI7fNUjbctXuWZL5o5TGuACc+pprXKxFGRsH+8f8KqklTvhKszDv0p8qM7Kzjlh0Xn3osO0VYmiYNJ94cHJHX35pty8Q2g/eY4BB6mobdBAznOQcHnt3ouBHIwbLZVs8UxNrm8h0c6jKKPmGM81C8h5baTnqvcGq+Z4rxZNgZOuR6VLJIsW5myAeBQVyq+mtyRpkYxrkBiOV/z7VGSp2tuI7Y9azJX3X8bgEjj24/yauKxUyMuNxJwD69aSKlBQtYtO/cjNUL64RFeMg7hk59MinQTsFJZQPmJPJ9vasa/mP2vJwSQAMDjPHX24qh0YXkasMKtbsoBHRskHtVNiwiJVjyOuBTBcBgPkOdu3rgY9auxMJI1ORuUcgfU0rdC7yhqxmnkjfuYrjnOPw/rUzxvLKCG+RTknHX0/nQoARFDD5CD17A5pZ5dxZcYLAAd/ekQ6l3cnjUxjA2hVHCD+p/z1pxlTbh3XntnrVVpCyheMYxkfWlMiTxuA3AGCfwp2MrdWJ5qzlim7cnyqSKQzSRxuGUb+2O9DPyR1LHPSq8hcSHKjAHXNUGjHzSJLCGdX7ZUDmkaU7AYCAxGfmHaowQMZOBjOaZI6BhIDxgr1/z6UyeYkaQgBRim7lVSeR7gVF5mFwMFe/NK04ABPIPX2oQhyTrJEwRgScZPv9KY0giO5yWI4z61WmkZHkA27X556im5i2ELu6g847U7Ddg8zMjScrzkd+tQtJ+75YYXp7UkhJ+nX/P51WYAHJ5q0EncSSZd52gk9CfeuI8U3IOop5YQ4jAP7wDByeOa7CR9rMy8nODmuP8AFVusmpIzE5MQ4H1NbU7X1Oau/cO5unCoW2hiOqvwD78/l+FcFr6hPEN5hWRWkLAEY4PNdpcyLIm7IKyD5dwPU+mR1rjfFaA6hHNGrRxPEmFYdNo2nn6qa76iujxsO7SsLYyYfa3HFasEgGBwa5+3k+bcpIP15FaUFwAAcH8+1ckkelTlc3gVJOW4IA6e1T2xwm0HI59v88VlRy5BwDk9KtRSHBGDnrnPSsWjoUjaRwEKgjGQevSrFu53nJYg9RnrWUswwdv1BzVmObdtwOPXNZtGiZtQMWXJQKePzqzE5Dkkce9YvnsrkxnauMAZzUpvfKiBJ3lsDGfeo5SoJvY02bfLHgEBTyau+eBCrqQPVRWYlwCqB0I45J6HirAdSvYZ689amxo5XSTNUPlNwPGMY6U9ZWI3sWyfVulZ8c6iMsNzcZyOv+eKUSGRE3Jt2nOM0WJRqRyqkY3AZH97mmRkzEFl/iJHOMjHvVRpQ3BIK+54FKspT5uSAcBQOtFuoi1Jkg56nt60YQIBuy5HAI9qqrcKG+ZtvGOmD0pskoZh93A525oCxPLJGjKJHweoz61TvVW5uIRHLlO+OeaS7LSxHH3/AK8daghRo87ucHPHP4UrGsWormT1GyxNHdxtGNyg4PfGO9WSQJA+Rux93tUch3L8hKHPPPJGKZkAYZvmHQDk/lRYJTukWSSFBGOB3Hes25haSUFs7fQHHepJZWSQHcAgBz9eOtMnkYyIdxIGflxjOelVYiMnHVBBb+X5yupIyeSQcip4IwqMqnHYDFU2kbkRMoGcH/HpRLIyxqVZfcq3WixTk5O7ZPbOfNZQc4ypweh/zirkY3LgnocetZlo4lkDFcMvGT+P+fwqzcPgIFYqd3JHcd6LBN80rFkNuwBye9VXuDDczDbhc7snvTvOjXJVvnYYyo79qrjcXYyS7snOAM8entSSCLS3FhvHMD+WN5zgc5zT/NbyWkkG0gEcHFVXhGVMI8o5AwT1/wA809lAUCVC2ByeuRn/APVVJBUlFvQkMuYl3DBPc84696gB24UAhQAMDkf54/zmmmQDgqoJ75HpUG7GP7w9f5U7ELQkJMjEMdjEcFT3pwYqSu5cMeo/HmoGkUOGK44PQ4qC4nYlWTGwdQP/ANVNIL30JJDL5yPG7EcZG7ipp7hl3lV3HOfbpWe8xcMN2CTkc9KYZSBgud3qDVKJLsyWWRi4bBywGRnvzUUrnJAA2gkdahknO4Ake+P51XZ4w8jKQWPXnOKtR1JclYc8nJR2JzyAT0/zmuW8SXRiv1XaT+7HOfc1vS3CqcHr2HSuT8QsWvlJB+4P5mtacddTlrz00O2M6eSq/KcINh35A46j+dc/4hJktASjsI22g7TwpJOM/wDAqNDu0k07ymb5ozjG4LwRx3GehouGeS3u4Q+1XiJCk8Egg/yFdr1R5UVyyMS3l2jByT9MVoJMAnPPoayg65wgwc9hU8Zww54zyKwaO1OxvJcD5QM8jjB6VdhuApG5s+vNYcT7cHPbgirMUioCee1ZOJtGdzbinUjHPoatQXAQFG5HYDtWLFIOoPHerKS5bjcKzcTZSNqO4GMvnAzk/wCetTlo5URuy/Nj2/zisqM5VeecetSpLs+9zjPTFS4mkZNbGrDeiZ9is2F4wR19x/nvV9ZPlT5sdyp/z+lYluyggx4UHBOB1FX45Ao5YYP86hxKjLQ0pJcxkRsQVIzgdvSpUm2qC7E5yMkYzWSsmGIJ57DHFPuHVpGKnA47YqOUvyNczFvL8vb5WfmI9s1KZgWIBPTOKy7eRY8KW+QA9PXNPE6u6FQdnfI/z70OJN9S8rK0hDc+57VBEzDJZt2CSSOao7mySHAyO1TO2yMoTgtgrz0HajlKvYuCbCsSTgnGCPfika52xttyxHUcdaz3fBUxsF6ntkc/4U2NiAMZ2k8jvTUSX3Lkt7HEitMjKG6k9uP1qFbkSOGjY9wflHHJ/lVS8IdiEyPl+X24qPeFGB09BRaxWlti60odOW4DEDgEkfjUH2nzGZixVVPTuR0qurqRnB55+aqpJE0jAgDp+lNINC8LqMMoHOeSM5zS7t0ZK8A5ABOcVTgJijfd1PI5zmktZC0LhmO08DPFFi76XRcWVoAh565Jz1qWWcyINpJY56ccEVSt2LPL5mcZ4DelTBlAwPWiwpS1vbUtRblRd46kc5HrTzIofIbCEA49SB0zVMN8ihjyKRGZS5cqF7ZxRYjmb1Lc8wKqoPzgZJHSq7TuOC7EH3quJcSHc2QeBz09aWSRcAA7iemKrlEgZmLht3y9lpjy5bduwRwQTiop5kWZVUndgH61AJcksu7J/wA/407Dv1JvtKuAecHjDDH6Go/NDMAp+Xvz1qu7AqclQ3bH+frUbNtHzHAx3p2JcixI4GQp5HcCoHkIG5j+QqEygEYOAR3qnJM/OWJI6YqlEz52XWnXeOSeM/5/Sqiy4kJP8QGceoFVmdgx5+YjORULPtVgxGRxxWiiQ5FqWRWduhI6VzmtPuu1P+x/U1oyHOCpxWNev5ly5zkDgVpFWOepK6sf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blanching erythematous rash with some confluent areas on the trunk in a patient with measles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright Dr. Michael Bennish; reproduced with his permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Boy with measles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 143px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Source: Centers for Disease Control and Prevention.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41185=[""].join("\n");
var outline_f40_14_41185=null;
var title_f40_14_41186="Anaphylaxis treatment and prevention";
var content_f40_14_41186=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?40/14/41186/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41186/contributors\" id=\"au915\">",
"       F Estelle R Simons, MD, FRCPC",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?40/14/41186/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41186/contributors\" id=\"se560\">",
"       Bruce S Bochner, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?40/14/41186/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41186/contributors\" id=\"de128\">",
"       Anna M Feldweg, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?40/14/41186?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ANAPHYLAXIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Anaphylaxis is a potentially deadly allergic reaction that is rapid in onset. It is most often triggered by foods, medications, and insect stings. There are many other possible triggers.",
"    </p>",
"    <p>",
"     Anaphylactic reactions are unpredictable. Many people who experience it have a known allergy. Some have had one or more milder allergic reactions previously. Others, who are not even aware that they have an allergy, can suddenly experience severe anaphylaxis. Even the first episode of anaphylaxis can be fatal.",
"    </p>",
"    <p>",
"     The severity of anaphylactic reactions can be minimized by recognizing the symptoms early, having proper medication available for self-treatment, and seeking emergency medical care promptly. This topic reviews the anaphylaxis treatment and prevention. Separate topics discuss the symptoms and diagnosis of anaphylaxis, and how to use an epinephrine autoinjector. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/57/15250?source=see_link\">",
"      \"Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/30/28134?source=see_link\">",
"      \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ANAPHYLAXIS TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     A person who has had an anaphylactic reaction should talk with their healthcare professional and develop an Anaphylaxis Emergency Action Plan for responding to future reactions. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"      \"Anaphylaxis: Rapid recognition and treatment\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Many people find that having an anaphylaxis treatment plan is reassuring, even if it is never needed. A critical component of the plan is having an epinephrine autoinjector available at all times and knowing when and how to use it. (See",
"     <a class=\"local\" href=\"#H4\">",
"      'Self-treatment with epinephrine'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Get emergency help",
"     </span>",
"     &nbsp;&mdash;&nbsp;Because anaphylaxis can be life-threatening, it should be treated as a medical emergency (",
"     <a class=\"graphic graphic_figure graphicRef82832 \" href=\"mobipreview.htm?36/53/37722\">",
"      figure 1",
"     </a>",
"     ). If you are experiencing a sudden allergic reaction that might be anaphylaxis, use your epinephrine autoinjector and then call 911 or emergency medical services (or have someone else call for you). If you are home alone, make sure that the door is unlocked so that the emergency team can enter.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Self-treatment with epinephrine",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have a history of anaphylaxis, you should always carry at least one epinephrine autoinjector with you at all times. A full description of epinephrine autoinjectors is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/30/28134?source=see_link\">",
"      \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Epinephrine is the only medicine that completely treats anaphylactic reactions. It is most effective when it is given promptly, before symptoms become severe. Neither antihistamines nor asthma inhalers (puffers) can treat anaphylaxis as effectively as epinephrine, and these medications cannot be substituted for epinephrine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Remove the cause",
"     </span>",
"     &nbsp;&mdash;&nbsp;The trigger for the anaphylactic reaction should be promptly removed, whenever possible. For example, if you have been stung by a bee and the stinger is still in the skin, flick it out immediately.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Go to the hospital",
"     </span>",
"     &nbsp;&mdash;&nbsp;After injecting epinephrine, it is important to be evaluated in a hospital emergency department. Up to 20 percent of people with anaphylaxis have a late-phase reaction, without further exposure to the trigger, and might require additional anaphylaxis treatment. There is no good way to predict whether a late-phase reaction will occur.",
"    </p>",
"    <p>",
"     In the emergency department, healthcare providers can monitor you, and if necessary, give oxygen, and insert a breathing tube (endotracheal tube) to keep the airways open until the reaction resolves. When needed, additional doses of epinephrine, intravenous (IV) fluids, and other medications can also be given.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      ANAPHYLAXIS PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     Anaphylaxis is a frightening experience. If you have had one anaphylactic reaction, you are at increased risk for another. It is normal to be anxious about this. The following steps can help to reduce the risk of a future anaphylactic reaction:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      See an allergist",
"     </span>",
"     &nbsp;&mdash;&nbsp;Anyone who has experienced an anaphylactic reaction should be evaluated by a doctor with specific training and experience in the diagnosis and treatment of anaphylaxis. Board-certified allergists have such training and experience. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/11/9401?source=see_link\">",
"      \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Testing to determine the trigger",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is important to try to confirm the cause of the anaphylactic reaction. Allergists can perform and interpret skin tests to confirm your specific anaphylaxis triggers (",
"     <a class=\"graphic graphic_figure graphicRef82830 \" href=\"mobipreview.htm?37/43/38586\">",
"      figure 2",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     For the most reliable results, skin tests should be performed at least three to four weeks after an anaphylactic reaction, because if done too soon after the event, such tests may give negative results when the person truly does have an allergy. Antihistamines and certain other medications need to be stopped for at least four days before these tests are performed.",
"    </p>",
"    <p>",
"     Blood tests can be performed immediately after an anaphylactic reaction and medications do not interfere with the results.",
"    </p>",
"    <p>",
"     In some cases, allergy tests do not identify any specific trigger. This condition is called idiopathic anaphylaxis. It is more common in adults than in children. An allergist can provide the best advice about how to manage this condition.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Avoiding triggers",
"     </span>",
"     &nbsp;&mdash;&nbsp;When a trigger has been identified, you should avoid it. However, avoiding some triggers, such as common foods, can be difficult.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Foods",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have experienced an anaphylactic reaction due to a food, you should eliminate that food from your diet. This requires that you read and understand food labels and ask about the preparation and content of all foods eaten when away from home. This recommendation applies to everything that you plan to eat, not just the foods that are most likely to contain the trigger. More information about food allergy treatment and prevention is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/47/29429?source=see_link\">",
"      \"Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/35/35379?source=see_link\">",
"      \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     An allergist can provide strategies for identifying allergens in processed foods and when dining out. In addition, practical information is available online from the Food Allergy and Anaphylaxis Network (",
"     <a class=\"external\" href=\"file://www.foodallergy.org/\">",
"      www.foodallergy.org",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Insect stings",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with an allergy to a stinging insect (bees, yellow jackets, wasps, hornets, or fire ants) should wear protective clothing, including closed shoes, and, if allergic to yellow jackets, should avoid drinking from open beverage containers and eating outdoors. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6502?source=see_link\">",
"      \"Bees, yellow jackets, hornets, and wasps: Avoidance\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/44/19138?source=see_link\">",
"      \"Patient information: Fire ants (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     A course of allergy shots is recommended for anyone who has had an anaphylactic reaction after an insect sting. The injections are given over several years. They dramatically reduce the person's risk of another episode of anaphylaxis. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16936?source=see_link\">",
"      \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have an allergy to a medication, you should learn all the names of that medication and the settings in which you are likely to encounter it. Ask your healthcare providers to note your allergy in your medical record and on your medical identification device (see below).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Wear medical identification",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who have experienced an anaphylactic reaction should wear a medical identification bracelet or similar medical identification tag at all times. If another reaction occurs and you are too ill to explain your condition, the words \"anaphylaxis\" or \"anaphylactic reaction\" will help emergency responders provide prompt and proper care.",
"    </p>",
"    <p>",
"     The tag should include a list of known allergies, as well as the names and phone numbers of emergency contacts. One device, Medic Alert&reg; (",
"     <a class=\"external\" href=\"file://www.medicalert.org/\">",
"      www.medicalert.org",
"     </a>",
"     ), provides a toll-free number that emergency medical workers can call to find out a person's medical history, list of medications, emergency contact numbers, and healthcare provider names and numbers.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498661921\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12677706\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/30/33250?source=see_link\">",
"      Patient information: Anaphylaxis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/27/35250?source=see_link\">",
"      Patient information: Food allergy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/57/29586?source=see_link\">",
"      Patient information: Epinephrine auto-injectors (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/31/1523?source=see_link\">",
"      Patient information: Angioedema (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/42/25250?source=see_link\">",
"      Patient information: Insect allergy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/35/17971?source=see_link\">",
"      Patient information: Peanut allergy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/3/23603?source=see_link\">",
"      Patient information: Drug allergy (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12677743\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/57/15250?source=see_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/30/28134?source=see_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/47/29429?source=see_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/35/35379?source=see_link\">",
"      Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/44/19138?source=see_link\">",
"      Patient information: Fire ants (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/1/12313?source=see_link\">",
"      Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/29/14808?source=see_link\">",
"      Clinical manifestations of food allergy: An overview",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/30/14824?source=see_link\">",
"      Diagnosis of Hymenoptera venom allergy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5321?source=see_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38888?source=see_link\">",
"      Differential diagnosis of anaphylaxis in children and adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link\">",
"      Drug eruptions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1241?source=see_link\">",
"      Fatal anaphylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/0/38920?source=see_link\">",
"      Food-induced anaphylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/17/26904?source=see_link\">",
"      History and physical examination in the patient with possible food allergy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/36/31305?source=see_link\">",
"      Immediate hypersensitivity reactions to radiocontrast media: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/54/40809?source=see_link\">",
"      Laboratory tests to support the clinical diagnosis of anaphylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=see_link\">",
"      Pathophysiology of anaphylaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/11/9401?source=see_link\">",
"      Anaphylaxis: Confirming the diagnosis and determining the trigger(s)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6502?source=see_link\">",
"      Bees, yellow jackets, hornets, and wasps: Avoidance",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16936?source=see_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aaaai.org/patients/gallery/anaphylaxis.asp\">",
"        www.aaaai.org/patients/gallery/anaphylaxis.asp",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American College of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.acaai.org/\">",
"        www.acaai.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Anaphylaxis Foundation and Anaphylaxis Network of Canada",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.anaphylaxis.org/\">",
"        www.anaphylaxis.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Anaphylaxis Campaign",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.anaphylaxis.org.uk/\">",
"        www.anaphylaxis.org.uk",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Food Allergy and Anaphylaxis Network",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.foodallergy.org/anaphylaxis/index.html\">",
"        www.foodallergy.org/anaphylaxis/index.html",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?40/14/41186/abstract/1\">",
"      1",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?40/14/41186?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41186/abstract/1\">",
"      Simons FE, Ardusso LR, Bil&ograve; MB, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127:587.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f40_14_41186=[""].join("\n");
var outline_f40_14_41186=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ANAPHYLAXIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ANAPHYLAXIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           ANAPHYLAXIS PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/53/37722\" title=\"figure 1\">",
"           Basic management of anaphylaxis",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/43/38586\" title=\"figure 2\">",
"           Anaphylaxis mechanisms and triggers",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41187="Alcaftadine: Patient drug information";
var content_f40_14_41187=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alcaftadine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/24/38274?source=see_link\">",
"     see \"Alcaftadine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F11392625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lastacaft&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F11386544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F11386485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2996760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alcaftadine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F11386487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug to treat contact lens irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696951",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wear contact lenses if your eyes are red.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F11386547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F11386489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F11386546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 10 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F11386486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F11386548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F11386490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16071 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41187=[""].join("\n");
var outline_f40_14_41187=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11392625\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386544\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386485\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386487\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386547\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386489\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386546\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386486\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386548\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11386490\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/24/38274?source=related_link\">",
"      Alcaftadine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41188="Tiludronate: Patient drug information";
var content_f40_14_41188=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tiludronate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/51/38709?source=see_link\">",
"     see \"Tiludronate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F227853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Skelid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Paget's disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tiludronate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701337",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to stand or sit up for 30 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697223",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have GI (gastrointestinal) disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696854",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take calcium, aspirin, indomethacin, or antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone, joint, or muscle pain may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A broken leg may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698193",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the jaw bone may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad jaw pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone, joint, or muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad groin or thigh pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach before breakfast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water at least 2 hours before the first food, drink, or drugs of the day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695915",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with plain water only. Avoid taking with mineral water or other drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not lie down for at least 30 minutes after taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in foil pouch until ready for use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11094 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-961E418322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41188=[""].join("\n");
var outline_f40_14_41188=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227853\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025133\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025132\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025137\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025138\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025140\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025135\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025136\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025141\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025142\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/51/38709?source=related_link\">",
"      Tiludronate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41189="Bells palsy photos PI";
var content_f40_14_41189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F59425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F59425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Bell's palsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 522px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This person with Bell's palsy has:",
"    <br>",
"     <ul>",
"      <li>",
"       Trouble raising his left eyebrow and wrinkling the left side of his forehead (shown in A)",
"      </li>",
"      <li>",
"       Trouble closing his left eye and raising the left corner of his mouth (shown in B)",
"      </li>",
"      <li>",
"       Drooping at the left corner of his mouth and trouble closing his left eye (shown in C)",
"      </li>",
"     </ul>",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Charles Goldberg, MD and The University of California, San Diego. Copyright &copy; 2005 The Regents of the University of California. file://medicine.ucsd.edu/clinicalimg/neuro-central-CN7-palsy2.html.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41189=[""].join("\n");
var outline_f40_14_41189=null;
var title_f40_14_41190="Congenital CMV";
var content_f40_14_41190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital cytomegalovirus (CMV) infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Congenital CMV infection with involvement of a renal tubule in a 32 week autolyzed stillbirth. In recurrent CMV infections which lead to fetal death, maternal evaluation for HIV infection is indicated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41190=[""].join("\n");
var outline_f40_14_41190=null;
var title_f40_14_41191="Unsafe abortion";
var content_f40_14_41191=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Unsafe abortion",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Melissa L Gilliam, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Sadia Haider, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Mimi Zieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41191/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/14/41191/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H18736521\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 205 million pregnancies occur worldwide each year and 42 million of these pregnancies end in abortion. Approximately 22 million of these abortions are &ldquo;safe&rdquo; and the other 20 million are &ldquo;unsafe&rdquo; (see",
"    <a class=\"local\" href=\"#H31293276\">",
"     'Definition of safe and unsafe abortion'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/1\">",
"     1",
"    </a>",
"    ]. Unsafe abortion is a major factor in maternal morbidity and mortality. One in four women undergoing an unsafe abortion will have a major complication and one in eight pregnancy-related deaths are the result of unsafe abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/1\">",
"     1",
"    </a>",
"    ]. Unsafe abortion has large economic costs, as well, since the incomplete procedure creates a need for hospital care.",
"   </p>",
"   <p>",
"    The risk of complications and death from unsafe abortion is inversely related to the provider&rsquo;s skill, conditions for performing the procedure, and availability of appropriate equipment. Some unsafe abortions are self-induced; the consequences in these cases also depend on whether the woman seeks medical care. Social stigma, legal threats, and fear can prevent women from accessing post-abortion care, which is a critical aspect of saving lives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2000, 189 nations pledged to free people from extreme poverty and multiple deprivations. This pledge became the eight Millennium Development Goals, which are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      End poverty and hunger",
"     </li>",
"     <li>",
"      Universal education",
"     </li>",
"     <li>",
"      Gender equality",
"     </li>",
"     <li>",
"      Child health",
"     </li>",
"     <li>",
"      Maternal health",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased efforts to provide access to safe abortion services has been identified as one of the three most important interventions for improving maternal health and reducing maternal mortality in resource poor settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/4\">",
"     4",
"    </a>",
"    ]. The other interventions are improved access to contraception and increased access to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    to control postpartum hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/5/28761?source=see_link\">",
"     \"Approaches to reduction of maternal mortality in resource-limited settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31293276\">",
"    <span class=\"h1\">",
"     DEFINITION OF SAFE AND UNSAFE ABORTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) defines &ldquo;safe&rdquo; abortion as abortion in countries where abortion law is not restrictive (abortion is legally permitted for social or economic reasons, or without specification as to reason) or countries in which, despite formal law, safe abortion is broadly available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/5\">",
"     5",
"    </a>",
"    ]. Conversely, &ldquo;unsafe&rdquo; abortion is performed by people lacking the necessary skills or using hazardous technique,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    in an environment that does not meet minimum medical standards. The WHO has adopted a focus on safety to emphasize the procedure and its context rather than placing blame on the women undergoing the procedure or emphasizing its legality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/6\">",
"     6",
"    </a>",
"    ]. Spontaneous miscarriages in which sepsis or other complications occur are also classified as unsafe abortion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31293283\">",
"    <span class=\"h1\">",
"     PREVALENCE AND EPIDEMIOLOGY OF UNSAFE ABORTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is estimated that 19.7 million unsafe abortions occur worldwide and 98 percent of these abortions occur in the developing world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/7\">",
"     7",
"    </a>",
"    ]. Obtaining accurate data on abortion safety is difficult, as unsafe abortion most commonly occurs in countries in which the procedure is highly restricted; therefore, the procedures occur under a cloud of secrecy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/8\">",
"     8",
"    </a>",
"    ]. While country-specific data on unsafe abortion vary, the regional rate appears to be highest in Africa (8.8 per 1000 women per year; 1.7 million), Latin America and the Caribbean (estimated rate of 7.7 per 1000 women per year; 1.1 million), and lower in Asia (4.1 per 1000 women or 2.3 million), excluding Eastern Asia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/9\">",
"     9",
"    </a>",
"    ]. These numbers are estimated based on rates of hospital admissions from complications of induced abortion and data from five countries.",
"   </p>",
"   <p>",
"    Socioeconomic risk determinants of unsafe abortion vary among countries. Developing countries are more likely to restrict access to legal abortion than developed countries, and this restriction affects poorer women disproportionately, leading to a higher proportion of unsafe abortion among the poor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/10\">",
"     10",
"    </a>",
"    ]. Even in countries with less restrictive abortion law, women most vulnerable to unsafe abortions are those who are younger, poorer, and lack partner support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736535\">",
"    <span class=\"h1\">",
"     PROVIDERS AND PERFORMANCE OF UNSAFE ABORTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risks and efficacy of unsafe abortion are dependent on the type of practitioner providing the service and the method. Unsafe abortions are performed by both trained medical practitioners (eg, physicians, nurses, midwives, pharmacists) and traditional lay practitioners [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, many women self-induce abortion. Traditionally, in many places where abortion has been illegal and unsafe, a woman attempts instrumentation of the uterus in order to induce bleeding. Once the diagnosis of &ldquo;spontaneous abortion&rdquo; is made, the woman can obtain appropriate medical care.",
"   </p>",
"   <p>",
"    In some large urban settings, women who can afford to pay a physician may be able to find one who performs abortion discreetly in",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    office by dilation and curettage or vacuum aspiration. Some physicians offer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    or initiate an abortion surgically and then advise women to present to a hospital for completion of an incomplete abortion. In rural areas, midwives and nurses provide similar services. These procedures can be unsafe even in the hands of medical providers due to the lack of adequate training, clean instruments, and sterile technique.",
"   </p>",
"   <p>",
"    Often, traditional lay practitioners or women themselves induce abortion with a wide range of methods that can be classified into four broad categories: oral and injectable treatments; preparations placed in the cervix, vagina, or rectum; intrauterine instrumentation; and trauma to the abdomen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. The wide range of methods used for unsafe abortion demonstrates how desperate women can be when faced with an unplanned pregnancy and what they are willing to endure to have an abortion, despite the risks. Many women resort to a combination of approaches and often initiate the process themselves with homemade remedies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral and injectable treatments include: metal salts, phosphorus, lead, kerosene, turpentine, detergent solutions, uterine stimulants (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       oxytocin",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/54/25447?source=see_link\">",
"       chloroquine",
"      </a>",
"      , oral contraceptives, hormones (gynaecosid), and numerous teas and herbal remedies.",
"     </li>",
"     <li>",
"      Preparations placed in the cervix, vagina, or rectum include: potassium permanganate tablets, herbal preparations,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      , enemas.",
"     </li>",
"     <li>",
"      Instrumentation of the uterus includes: catheter insertion followed by infusion of alcohol, saline, or other solution; insertion of foreign bodies such as coat hanger, knitting needle, stick crochet hook, or air blown through a syringe. Penetration with sharp objects with potential for uterine perforation and use of unclean instruments such as unsterilized catheters are methods that pose the highest risks for morbidity and mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, transcervical introduction of compounds such as mixtures of soap, cresol and phenol can cause renal toxicity, cardiac toxicity, and death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Trauma to the abdomen including: self-inflicted blows, abdominal massage, jumping from a height, lifting heavy weights. Traditional practitioners commonly use vigorous abdominal massage with the idea that this will result in disruption of the pregnancy, but this can result in uterine rupture or other morbidity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18243268\">",
"    <span class=\"h2\">",
"     Misoprostol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing access to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    in many parts of the world has altered the way in which many women obtain abortions despite the lack of legal and safe access to abortion care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/12\">",
"     12",
"    </a>",
"    ]. If misoprostol is administered with sufficient dosing and frequency (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28330?source=see_link\">",
"     \"Misoprostol as a single agent for medical termination of pregnancy\"",
"    </a>",
"    ), it can result in successful abortion for many women and with a low risk of complications. In other cases, misoprostol causes uterine bleeding by initiating the abortion process without the risks of instrumentation. The woman can then obtain appropriate medical care for symptoms of spontaneous abortion. &nbsp;",
"   </p>",
"   <p>",
"    In Brazil, as is the case in many other developing countries, women have recognized the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    as a method of abortion and many women self-administer the medication to induce bleeding. This has resulted in a significantly lower infection rate from unsafe abortion in Brazil than with alternative traditional methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In Columbia, experts estimated that half of women obtaining abortions used",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    , which could be obtained from a variety of informal sources; however, complications related to abortion have increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/20\">",
"     20",
"    </a>",
"    ]. This may be because women often have inaccurate information on misoprostol use, and drug quality is a major concern, since a variety of misoprostol products on the market do not meet international standards, are poorly stored, or have expired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/21\">",
"     21",
"    </a>",
"    ]. Shopkeepers have sold hormonal contraceptive pills, analgesics, and antibiotics to women who request a medicine to terminate pregnancy. Increased dissemination of accurate information on misoprostol use and access to high-quality drugs could reduce abortion complications related to this drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736549\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One in four women undergoing an unsafe abortion will have a major complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/1\">",
"     1",
"    </a>",
"    ]. In the developing world, it is estimated that five million women are admitted to hospitals for treatment of complications from induced abortions each year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review evaluated 43 studies of abortion-related complications in areas where most abortions are unsafe (14 countries in Africa, 6 countries in Asia, 4 countries in Latin America) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/22\">",
"     22",
"    </a>",
"    ]. Among women hospitalized with abortion-related complications, the type and median prevalence of complications were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Renal failure: 1.6 percent",
"     </li>",
"     <li>",
"      Hemorrhage: severe 3 percent, nonsevere or unspecified 44.2 percent",
"     </li>",
"     <li>",
"      Infection: severe 5.1 percent, nonsevere or unspecified 24 percent",
"     </li>",
"     <li>",
"      Trauma: severe 7.2 percent, nonsevere or unspecified 5.5 percent",
"     </li>",
"     <li>",
"      Anemia: 38.1 percent",
"     </li>",
"     <li>",
"      Case fatality: 3.3 percent (range 0 to 22 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most women had more than one complication.",
"   </p>",
"   <p>",
"    Factors that increase morbidity and mortality at the time of unsafe abortion include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lack of provider skill",
"     </li>",
"     <li>",
"      Poor technique",
"     </li>",
"     <li>",
"      Unsanitary conditions for performing the procedure",
"     </li>",
"     <li>",
"      Lack of appropriate equipment",
"     </li>",
"     <li>",
"      Use of toxic substances",
"     </li>",
"     <li>",
"      Poor maternal health",
"     </li>",
"     <li>",
"      Increasing gestational age",
"     </li>",
"     <li>",
"      Lack of access to post-abortion care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, social stigma, legal threats, and fear can prevent women who undergo unsafe abortion from accessing post-abortion care, which is a critical aspect of reducing morbidity and saving lives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31294168\">",
"    <span class=\"h2\">",
"     Death",
"    </span>",
"    &nbsp;&mdash;&nbsp;One in eight pregnancy-related deaths worldwide is the result of unsafe abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/1\">",
"     1",
"    </a>",
"    ] and an estimated 68,000 women die every year from unsafe abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/13\">",
"     13",
"    </a>",
"    ]. Death due to unsafe abortion varies by country, with rates as disparate as 0 to 49 percent; however, these numbers are subject to underreporting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736873\">",
"    <span class=\"h2\">",
"     Hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhage is the most common complication of unsafe abortion, and may result in hypovolemic shock, coagulopathy, and death. Hemorrhage may be related to lacerations of the vagina, cervix, uterus, or adnexal vasculature; uterine infection;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atony. Retained products of conception are a common cause of uterine infection and atony.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736880\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection related to unsafe abortion is caused by retained products of conception, trauma, and non-sterile techniques. If untreated or inappropriately treated, infection can lead to sepsis, septic shock, organ failure, disseminated intravascular coagulation, and future sterility. Women may present with one or more of the following signs and symptoms anytime from minutes to days after the procedure: abdominal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pelvic pain, malodorous discharge, fever and chills, bleeding or spotting, and uterine or adnexal tenderness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736887\">",
"    <span class=\"h2\">",
"     Incomplete abortion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incomplete abortion is more common in self-induced abortion or abortion by an untrained provider, at later gestational ages, in the presence of uterine anomalies, or with distorting uterine pathology (eg, uterine leiomyomas). Patients generally present with bleeding or infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31294295\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insertion of a foreign body is a common cause of abortion-related trauma. In addition to injuries to the genital tract, perforation can result in trauma to the bowel and other internal organs. Ingestion of chemical agents can also cause trauma. &nbsp;",
"   </p>",
"   <p>",
"    Vaginal and cervical lacerations generally present with overt vaginal bleeding; however, internal bleeding can mask the total estimated blood loss. Lacerations to the cervix and lateral uterus are particularly dangerous due to the risk of lacerating one of the vessels in the parametrial space. A vaginal or cervical laceration should be suspected in the setting of heavy vaginal bleeding with firm uterine tone.",
"   </p>",
"   <p>",
"    Uterine perforation is the most common upper genital tract injury. Other sites of trauma from perforation include the fallopian tubes, ovaries, bowel, rectum, and bladder. Presenting signs and symptoms include vaginal bleeding, hemodynamic instability, and sepsis. In addition, the provider may suspect perforation based on findings during the procedure (eg, visualization of a laceration or internal organ, feeling an instrument perforate tissue, ability to insert instruments deep into the patient).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736908\">",
"    <span class=\"h2\">",
"     Chemical burns or drug toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who have used or been administered oral, parenteral, or local drugs or toxic substances for abortion induction or assistance in surgical abortion may have a variety of presentations, including local damage to the vagina or signs of renal or liver toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31294317\">",
"    <span class=\"h2\">",
"     Failed procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ongoing pregnancy may result from a botched abortion at an early gestational age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31294123\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the initial medical assessment of reproductive age women, the clinician should always consider the possibility of pregnancy. Following unsafe abortion, women may present to several different types of facilities, they may have a variety of presentations, and they may not reveal a history of recent abortion or even that they are or were pregnant.",
"   </p>",
"   <p>",
"    When a woman presents with clinical findings related to the genital tract, providers in countries where abortion is legal may not consider the possibility of unsafe abortion, since it is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/2\">",
"     2",
"    </a>",
"    ]. However, this possibility should be considered in complicated or atypical cases, since standard approaches to management of gynecological disease may be inadequate in women who have been exposed internally to chemicals or nonsterile implements or who have ingested toxic substances (see",
"    <a class=\"local\" href=\"#H18736535\">",
"     'Providers and performance of unsafe abortion'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    In countries where abortion is restricted, complications from unsafe abortion are a common reason for hospital admission. For example, in Nigeria, unsafe complicated abortions accounted for 14 percent of gynecological admissions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/23\">",
"     23",
"    </a>",
"    ]. In resource-limited settings, a major issue is triage to a facility with adequate resources to support the patient and manage her",
"    <span class=\"nowrap\">",
"     medical/surgical",
"    </span>",
"    needs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18242723\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial evaluation includes assessment of vital signs, gestational age, vaginal bleeding and total blood loss, vaginal discharge, and examination for signs of uterine infection (malodorous discharge, uterine tenderness, fever). Signs of potential surgical emergency include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Heavy bleeding",
"     </li>",
"     <li>",
"      Abdominal pain",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"     <li>",
"      Shock",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Facilities unable to manage complications of abortion should stabilize the patient and arrange for transport to an appropriate facility. Stabilization may include airway and respiratory stabilization, fluid resuscitation, management of pain, and control of bleeding with uterine massage, uterotonic agents (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    &nbsp;800 mcg per rectum or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"     methylergonovine",
"    </a>",
"    &nbsp;0.2 mg orally or intramuscularly),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    placement of a",
"    <span class=\"nowrap\">",
"     vaginal/intrauterine",
"    </span>",
"    pack",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an intrauterine balloon. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22711?source=see_link\">",
"     \"Intrauterine balloon tamponade for control of postpartum hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/60/41929?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of postpartum hemorrhage at vaginal delivery\", section on 'Packs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In facilities with appropriate equipment, drugs, and personnel, the general approach to management includes the following interventions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Administration of intravenous fluids, volume expanders, and blood products, as needed.",
"     </li>",
"     <li>",
"      Surgical repair of actively bleeding lower genital tract lacerations. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44071?source=see_link\">",
"       \"Evaluation and management of lower genital tract trauma in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/4/16455?source=see_link\">",
"       \"Management of hematomas incurred as a result of obstetrical delivery\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Laparotomy is needed to repair lacerations extending into the peritoneal cavity and trauma to intraabdominal organs and blood vessels. In stable patients, initial laparoscopy may be appropriate to assess intraabdominal trauma and may allow avoidance of laparotomy if bleeding is controlled and bowel and blood vessels are intact. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/19/4408?source=see_link&amp;anchor=H16#H16\">",
"       \"Uterine perforation during gynecologic procedures\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/19/4408?source=see_link&amp;anchor=H20#H20\">",
"       \"Uterine perforation during gynecologic procedures\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If the uterus is atonic, uterine massage and administration of uterotonic agents (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      800 mcg per rectum or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"       methylergonovine",
"      </a>",
"      &nbsp;0.2 mg orally or intramuscularly), an intrauterine pack,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an intrauterine balloon. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22711?source=see_link\">",
"       \"Intrauterine balloon tamponade for control of postpartum hemorrhage\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      However, if retained products of conception are suspected, the patient should first undergo surgical evacuation of the uterus using suction evacuation or dilatation and evacuation as necessary. The amount of retained tissue is particularly difficult to estimate after unsafe abortion and is likely to be greater than after safe abortion. Antibiotics should be given prior to instrumentation. A variety of regimens is effective. It is important to use broad spectrum antibiotics that have anaerobic coverage. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39384?source=see_link\">",
"       \"Retained products of conception\"",
"      </a>",
"      .)",
"      <br/>",
"     </li>",
"     <li>",
"      Common clinical features of septic abortion include fever, chills, malaise, abdominal pain, vaginal bleeding, and discharge, which is often sanguinopurulent. Physical examination may reveal tachycardia, tachypnea, lower abdominal tenderness, and a boggy, tender uterus with dilated cervix.",
"      <br/>",
"      <br/>",
"      Infection is usually due to Staphylococcus aureus, Gram negative bacilli, or some Gram positive cocci. Mixed infections, anaerobic organisms, and fungi, can also be encountered. The infection may spread, leading to salpingitis, generalized peritonitis, and septicemia.",
"      <br/>",
"      <br/>",
"      Antibiotic therapy and evacuation of the uterus are the mainstays of management. The route of antibiotic administration, oral versus parenteral, depends on degree of infection. Postabortal infections are typically polymicrobial and thus a broad-spectrum antibiotic is needed. An oral regimen is reasonable if the patient is clinically stable, not immunocompromised, does not have signs of a pelvic abscess, and will adhere to the regimen. An option for patients with mild to moderate pelvic inflammatory disease (PID) is one dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/53/11094?source=see_link\">",
"       cefoxitin",
"      </a>",
"      2 grams intramuscularly plus one dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/18/37157?source=see_link\">",
"       probenecid",
"      </a>",
"      1 gram orally, followed by",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      100 mg twice daily orally for 14 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/24\">",
"       24",
"      </a>",
"      ]. For patients with more severe cases, broad-spectrum parenteral antibiotics are required until symptoms resolve.",
"     </li>",
"     <li>",
"      Manifestations of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      toxicity may include high fever, shaking chills, abdominal cramping, vomiting, diarrhea, tremor, agitation, confusion, rhabdomyolysis, hypoxemia, and hypotension [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/25-28\">",
"       25-28",
"      </a>",
"      ]. Symptoms develop soon after ingestion, as misoprostol is rapidly absorbed (it is completely absorbed from the stomach 1.5 hours after ingestion). Treatment involves removing any remaining tablets from the vagina or stomach (eg, gavage) and supportive care until symptoms resolve, which takes about 12 hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/25,26,28,29\">",
"       25,26,28,29",
"      </a>",
"      ]. Management of rhabdomyolysis is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32632?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21847?source=see_link\">",
"       \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Disseminated intravascular coagulopathy (DIC) is a rare but life-threatening complication of abortion. It is associated with prolonged fetal demise, excessive blood loss, and amniotic fluid embolism. DIC can be diagnosed by drawing a 10 cc tube of whole blood and assessing whether it forms a stable clot after 10 minutes without movement of the tube. Treatment involves fluid resuscitation, clotting factors, platelets, and blood transfusion, as necessary. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=see_link&amp;anchor=H25#H25\">",
"       \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31293484\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultimately, prevention of unsafe abortion requires a multipronged approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prevention of unintended pregnancy",
"     </li>",
"     <li>",
"      Improved access to and safety of abortion procedures",
"     </li>",
"     <li>",
"      Provision of high-quality postabortion medical care",
"     </li>",
"     <li>",
"      Postabortion family planning counseling and contraceptive services",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Provision of contraception is the most important intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/33\">",
"     33",
"    </a>",
"    ]. In the Russian Federation, Eastern Europe, and Central Asia, abortion levels declined steadily as the use of modern contraceptives increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Although a 2013 systematic review did not find conclusive evidence that post-abortion family planning counseling and services in low income countries significantly decreased maternal",
"    <span class=\"nowrap\">",
"     morbidity/mortality,",
"    </span>",
"    unintended pregnancy, or repeat abortion, the available evidence was sparse and low quality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/36\">",
"     36",
"    </a>",
"    ]. Studies in California and Helsinki have reported that postabortal intrauterine device (IUD) insertion decreased the rate of repeat abortion by over 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Expanded access to safe abortion is also critical. Liberalization of abortion laws resulted in increased access to safe abortion, most notably in Romania, where repeal of laws banning contraception and abortion was associated with a 50 percent fall in maternal mortality within one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/35\">",
"     35",
"    </a>",
"    ]. In the United States, the number of abortion-related deaths fell after Roe v Wade in 1973: from almost 40 per million live births in 1970 to 8 per million live births in 1976, in part due to the increased availability of legal abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/39\">",
"     39",
"    </a>",
"    ]. In Bangladesh, use of the safe, government sanctioned service of menstrual regulation establishing nonpregnancy after a missed period is associated with one-third the rate of complications of induced abortions: 120 per 1000 menstrual regulations versus 357 per 1000 induced abortions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/40\">",
"     40",
"    </a>",
"    ]. Menstrual regulation is usually performed by Family Welfare Visitors (women trained to conduct childbirth) using manual vacuum extraction.",
"   </p>",
"   <p>",
"    Victims of intimate partner violence are at risk for unintended pregnancy and abortion, as well as other health consequences. A study by the World Health Organization (WHO) estimated that reducing intimate partner violence by 50 percent could potentially reduce unintended pregnancy by 2 to 18 percent and abortion by 4.5 to 40 percent, according to population-attributable risk estimates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41191/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18736556\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unsafe abortion is defined by the World Health Organization (WHO) as an abortion performed by people lacking the necessary skills or using hazardous technique,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      in an environment that does not meet minimum medical standards. Spontaneous miscarriages in which sepsis or other complications occur are also classified as unsafe abortion. (See",
"      <a class=\"local\" href=\"#H31293276\">",
"       'Definition of safe and unsafe abortion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ninety-eight percent of unsafe abortions occur in the developing world. (See",
"      <a class=\"local\" href=\"#H31293283\">",
"       'Prevalence and epidemiology of unsafe abortion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unsafe abortion is performed by a variety of trained and untrained providers, or may be self-induced. The four major methodologies are (see",
"      <a class=\"local\" href=\"#H18736535\">",
"       'Providers and performance of unsafe abortion'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Oral and injectable treatments (eg, metal salts, phosphorus, lead, kerosene, turpentine, detergent solutions, uterine stimulants,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/54/25447?source=see_link\">",
"       chloroquine",
"      </a>",
"      , hormones, and numerous teas and herbal remedies).",
"     </li>",
"     <li>",
"      Preparations placed in the cervix, vagina, or rectum (eg, potassium permanganate tablets, herbal preparations,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      , enemas).",
"     </li>",
"     <li>",
"      Instrumentation of the uterus (eg, catheter insertion followed by infusion of some solution, insertion of a foreign body, air blown through a syringe).",
"     </li>",
"     <li>",
"      Trauma to the abdomen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One in four women undergoing an unsafe abortion will have a major complication. The most common complications are trauma, infection, and hemorrhage. Complications may lead to death or long-term sequelae. (See",
"      <a class=\"local\" href=\"#H18736549\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When a reproductive aged woman presents with clinical findings related to the genital tract, the clinician must have a heightened suspicion for unsafe abortion, as many women will not report the procedure or the pregnancy. (See",
"      <a class=\"local\" href=\"#H31294123\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications are managed by stabilization of the patient,",
"      <span class=\"nowrap\">",
"       medical/surgical",
"      </span>",
"      management of emergent conditions, and transfer to a facility with appropriate resources, if necessary. (See",
"      <a class=\"local\" href=\"#H18242723\">",
"       'Management of complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       Misoprostol",
"      </a>",
"      is commonly used to induce abortion. Manifestations of misoprostol toxicity may include high fever, shaking chills, abdominal cramping, vomiting, diarrhea, tremor, agitation, confusion, rhabdomyolysis, hypoxemia, and hypotension. Symptoms develop soon after ingestion. Treatment involves removing any remaining tablets from the vagina or stomach and supportive care until symptoms resolve, which takes about 12 hours. (See",
"      <a class=\"local\" href=\"#H18243268\">",
"       'Misoprostol'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18242723\">",
"       'Management of complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization, Department of Reproductive Health and Research. Unsafe abortion: global and regional estimates of incidence of unsafe abortion and associated mortality in 2003, 5th, WHO, Geneva 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/2\">",
"      Harris LH. Stigma and abortion complications in the United States. Obstet Gynecol 2012; 120:1472.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.un.org/millenniumgoals/bkgd.shtml (Accessed on July 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/4\">",
"      Prata N, Sreenivas A, Vahidnia F, Potts M. Saving maternal lives in resource-poor settings: facing reality. Health Policy 2009; 89:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/5\">",
"      Fawcus SR. Maternal mortality and unsafe abortion. Best Pract Res Clin Obstet Gynaecol 2008; 22:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/6\">",
"      Hessini L, Brookman-Amissah E, Crane BB. Global policy change and women's access to safe abortion: the impact of the World Health Organization's guidance in Africa. Afr J Reprod Health 2006; 10:14.",
"     </a>",
"    </li>",
"    <li>",
"     Singh S, Wulf D, Hussain R, Bankole A, Sedgh G. Abortion Worldwide: A Decade of Uneven Progress. file://www.guttmacher.org/pubs/Abortion-Worldwide.pdf; 2009.",
"    </li>",
"    <li>",
"     Sing S, Wulf D, Hussain R, et al. Abortion Worldwide: A Decade of Uneven Progress, Guttmacher Institute, New York 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/9\">",
"      Singh S. Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries. Lancet 2006; 368:1887.",
"     </a>",
"    </li>",
"    <li>",
"     Malarcher S, Olson LG, Hearst N. Unintended pregnancy and pregnancy outcome: equity and social determinants. In: Blas E, Kurup AS, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010. p. 177",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/11\">",
"      Sundaram A, Juarez F, Bankole A, Singh S. Factors associated with abortion-seeking and obtaining a safe abortion in Ghana. Stud Fam Plann 2012; 43:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/12\">",
"      Grimes DA. Unsafe abortion: the silent scourge. Br Med Bull 2003; 67:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/13\">",
"      Grimes DA, Benson J, Singh S, et al. Unsafe abortion: the preventable pandemic. Lancet 2006; 368:1908.",
"     </a>",
"    </li>",
"    <li>",
"     Sharing Responsibility: Women, Society &amp; Abortion Worldwide, The Alan Guttmacher Institute, New York 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/15\">",
"      Bury L, Aliaga Bruch S, Machicao Barbery X, Garcia Pimentel F. Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia. Int J Gynaecol Obstet 2012; 118 Suppl 1:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/16\">",
"      Burnhill MS. Treatment of women who have undergone chemically induced abortions. J Reprod Med 1985; 30:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/17\">",
"      Ugboma HA, Akani CI. Abdominal massage: another cause of maternal mortality. Niger J Med 2004; 13:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/18\">",
"      Costa SH. Commercial availability of misoprostol and induced abortion in Brazil. Int J Gynaecol Obstet 1998; 63 Suppl 1:S131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/19\">",
"      Fa&uacute;ndes A, Santos LC, Carvalho M, Gras C. Post-abortion complications after interruption of pregnancy with misoprostol. Adv Contracept 1996; 12:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/20\">",
"      Prada E, Singh S, Villarreal C. Health consequences of unsafe abortion in Colombia, 1989-2008. Int J Gynaecol Obstet 2012; 118 Suppl 2:S92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/21\">",
"      Hyman A, Blanchard K, Coeytaux F, et al. Misoprostol in women's hands: a harm reduction strategy for unsafe abortion. Contraception 2013; 87:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/22\">",
"      Adler AJ, Filippi V, Thomas SL, Ronsmans C. Quantifying the global burden of morbidity due to unsafe abortion: magnitude in hospital-based studies and methodological issues. Int J Gynaecol Obstet 2012; 118 Suppl 2:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/23\">",
"      Ibrahim IA, Onwudiegwu U. Sociodemographic determinants of complicated unsafe abortions in a semi-urban Nigerian town: a four-year review. West Indian Med J 2012; 61:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/24\">",
"      Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005; 106:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/25\">",
"      Bond GR, Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 1994; 171:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/26\">",
"      Austin J, Ford MD, Rouse A, Hanna E. Acute intravaginal misoprostol toxicity with fetal demise. J Emerg Med 1997; 15:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/27\">",
"      Bentov Y, Sheiner E, Katz M. Misoprostol overdose during the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/28\">",
"      Barros JG, Reis I, Gra&ccedil;a LM. Acute misoprostol toxicity during the first trimester of pregnancy. Int J Gynaecol Obstet 2011; 113:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/29\">",
"      Graber DJ, Meier KH. Acute misoprostol toxicity. Ann Emerg Med 1991; 20:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/30\">",
"      Fa&uacute;ndes A. Strategies for the prevention of unsafe abortion. Int J Gynaecol Obstet 2012; 119 Suppl 1:S68.",
"     </a>",
"    </li>",
"    <li>",
"     International Federation of Gynecology and Obstetrics, International Confederation of Midwives, International Council of Nurses, United States Agency for International Development. FIGO Consensus Statement. Family planning: a key component of post abortion care. Available at: file://www.figo.org/news/figo-consensus-statementfamily- planning-key-component-post-abortion-care. October 8, 2009.",
"    </li>",
"    <li>",
"     International Federation of Gynecology and Obstetrics. Consensus statement on uterine evacuation. Uterine evacuation: use vacuum aspiration or medications, not sharp curettage. Available at: file://www.figo.org/news/new-downloaduterineevacuation-figo-consensus-statement-003824. July 12, 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/33\">",
"      Cleland J, Conde-Agudelo A, Peterson H, et al. Contraception and health. Lancet 2012; 380:149.",
"     </a>",
"    </li>",
"    <li>",
"     Westoff CF, Recent trends in abortion and contraception in 12 countries, DHS Analytical Studies, Princeton, NJ, USA: Office of Population Research, Princeton University; and Calverton, MD, USA: ORC Macro, 2005, No. 8.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/35\">",
"      Stephenson P, Wagner M, Badea M, Serbanescu F. Commentary: the public health consequences of restricted induced abortion--lessons from Romania. Am J Public Health 1992; 82:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/36\">",
"      Tripney J, Kwan I, Bird KS. Postabortion family planning counseling and services for women in low-income countries: a systematic review. Contraception 2013; 87:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/37\">",
"      Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008; 78:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/38\">",
"      Heikinheimo O, Gissler M, Suhonen S. Can the outcome of the next pregnancy be predicted at the time of induced abortion? Hum Reprod 2009; 24:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/39\">",
"      Cates W Jr, Rochat RW, Grimes DA, Tyler CW Jr. Legalized abortion: effect on national trends of maternal and abortion-related mortality (1940 through 1976). Am J Obstet Gynecol 1978; 132:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/40\">",
"      Hossain A, Maddow-Zimet I, Singh S, Remez L. Menstrual regulation, unsafe abortion, and maternal health in Bangladesh. Issues Brief (Alan Guttmacher Inst) 2012; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41191/abstract/41\">",
"      Pallitto CC, Garc&iacute;a-Moreno C, Jansen HA, et al. Intimate partner violence, abortion, and unintended pregnancy: results from the WHO Multi-country Study on Women's Health and Domestic Violence. Int J Gynaecol Obstet 2013; 120:3.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14192 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-D1AB04EF24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41191=[""].join("\n");
var outline_f40_14_41191=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18736556\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18736521\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31293276\">",
"      DEFINITION OF SAFE AND UNSAFE ABORTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31293283\">",
"      PREVALENCE AND EPIDEMIOLOGY OF UNSAFE ABORTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18736535\">",
"      PROVIDERS AND PERFORMANCE OF UNSAFE ABORTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18243268\">",
"      Misoprostol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18736549\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31294168\">",
"      Death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18736873\">",
"      Hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18736880\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18736887\">",
"      Incomplete abortion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31294295\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18736908\">",
"      Chemical burns or drug toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31294317\">",
"      Failed procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31294123\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18242723\">",
"      MANAGEMENT OF COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31293484\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18736556\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/5/28761?source=related_link\">",
"      Approaches to reduction of maternal mortality in resource-limited settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44071?source=related_link\">",
"      Evaluation and management of lower genital tract trauma in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22711?source=related_link\">",
"      Intrauterine balloon tamponade for control of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/4/16455?source=related_link\">",
"      Management of hematomas incurred as a result of obstetrical delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/60/41929?source=related_link\">",
"      Management of postpartum hemorrhage at vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28330?source=related_link\">",
"      Misoprostol as a single agent for medical termination of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39384?source=related_link\">",
"      Retained products of conception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/19/4408?source=related_link\">",
"      Uterine perforation during gynecologic procedures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41192="Oculopharyngeal, distal, and congenital muscular dystrophies";
var content_f40_14_41192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Oculopharyngeal, distal, and congenital muscular dystrophies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Basil T Darras, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41192/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/14/41192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The muscular dystrophies are an inherited group of progressive myopathic disorders resulting from defects in a number of genes required for normal muscle function. Some of the genes responsible for these conditions have been identified. Muscle weakness is the primary symptom.",
"   </p>",
"   <p>",
"    The pathogenesis, genetics, and clinical characteristics of oculopharyngeal, distal, and congenital muscular dystrophies are discussed here. Other muscular dystrophies are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/16/1290?source=see_link\">",
"     \"Clinical features and diagnosis of Duchenne and Becker muscular dystrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21415?source=see_link\">",
"     \"Emery-Dreifuss muscular dystrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/34/26153?source=see_link\">",
"     \"Facioscapulohumeral muscular dystrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=see_link\">",
"     \"Limb-girdle muscular dystrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/26/19882?source=see_link\">",
"     \"Myotonic dystrophy: Etiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OCULOPHARYNGEAL MUSCULAR DYSTROPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathy that is characterized by ocular and pharyngeal muscle involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;OPMD typically presents with ptosis, dysarthria, and dysphagia. It can also be associated with proximal and distal extremity weakness. The onset is usually in middle age with asymmetric involvement of the levator palpebrae muscles. Progressive extraocular weakness subsequently develops. In general, OPMD is a slowly progressive myopathy. However, ptosis can occlude vision, and severe dysphagia may lead to weight loss and death if not treated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;OPMD is distinguished from facioscapulohumeral dystrophy (FSHD) by the different distributions of weakness. Extraocular weakness is far more severe in OPMD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/34/26153?source=see_link\">",
"     \"Facioscapulohumeral muscular dystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    OPMD is distinguished from myotonic dystrophy because myotonia is absent in the former. Ocular muscle involvement is rarely severe in early myotonic dystrophy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/26/19882?source=see_link\">",
"     \"Myotonic dystrophy: Etiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Differentiation from a mitochondrial myopathy may be more difficult. However, mitochondrial myopathies often have associated features such as retinitis pigmentosa, ataxia, elevated cerebrospinal fluid protein, cardiac conduction defects, and developmental delay that are absent in OPMD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/56/905?source=see_link\">",
"     \"Approach to the metabolic myopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle biopsy shows variation of fiber size and \"rimmed\" vacuoles. Serum CK levels may be elevated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;OPMD is an autosomal dominant myopathy with complete penetrance. The incidence is relatively high in the Canadian province of Quebec, where it is estimated at one in 8000 individuals. The frequency of OPMD in France is lower, at one in 200,000 individuals. A single founder chromosome appears to be responsible for OPMD in the French-Canadian population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disease has also been described in the Uzbek Jews living in Israel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], and Ashkenazi Jews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/1\">",
"     1",
"    </a>",
"    ] and Hispanics living in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    OPMD has been linked to chromosome 14q11.2-q13, and a GCG repeat expansion has been shown in the polyadenylate binding protein nuclear 1 gene (PABPN1, previously called PABP2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/8\">",
"     8",
"    </a>",
"    ]. In one study, 98 percent of control French-Canadian chromosomes had six GCG repeats and 2 percent had seven repeats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/9\">",
"     9",
"    </a>",
"    ]. In OPMD, the expanded alleles range from eight to 13 repeats. The OPMD repeat is relatively short, with small and relatively stable expansions. The polyadenylate binding protein nuclear 1 localizes to the nucleus, where it seems to be involved in mRNA polyadenylation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A severe form of OPMD with earlier onset and faster progression has been reported in patients who are homozygotes for the PABPN1 gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is supportive. In a small number of patients, cricopharyngeal myotomy has been attempted with improvement of the dysphagia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/13\">",
"     13",
"    </a>",
"    ]. In studies of a transgenic mouse model of OPMD,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    treatment delays disease onset and progression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, cystamine treatment improves muscle weakness, decreases apoptotic markers in muscle, and reduces the aggregate load of mutant PABPN1 within skeletal muscle nuclei [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/15\">",
"     15",
"    </a>",
"    ]. Cystamine reduces the toxicity of mutant PABPN1 by inhibiting transglutaminase 2 activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DISTAL MUSCULAR DYSTROPHIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal muscular dystrophies are a heterogeneous group of myopathies that include the following types [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonaka myopathy",
"     </li>",
"     <li>",
"      Miyoshi muscular dystrophy 1",
"     </li>",
"     <li>",
"      Miyoshi muscular dystrophy 3",
"     </li>",
"     <li>",
"      Welander distal myopathy",
"     </li>",
"     <li>",
"      Udd distal myopathy (tardive tibial muscular dystrophy)",
"     </li>",
"     <li>",
"      Markesbery-Griggs late onset distal myopathy (zaspopathy)",
"     </li>",
"     <li>",
"      Distal myotilinopathy",
"     </li>",
"     <li>",
"      Laing distal myopathy (MPD1)",
"     </li>",
"     <li>",
"      Distal myopathy with vocal cord and pharyngeal dysfunction (MPD2)",
"     </li>",
"     <li>",
"      Distal myopathy 3, Finnish (MPD3)",
"     </li>",
"     <li>",
"      Williams distal myopathy (MPD4)",
"     </li>",
"     <li>",
"      Distal myopathy with pes cavus and areflexia (vacuolar neuromyopathy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Their current clinical and genetic classification is shown in the Table (",
"    <a class=\"graphic graphic_table graphicRef51980 \" href=\"mobipreview.htm?7/23/7550\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    These disorders are characterized by weakness that starts distally in the arms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    legs and gradually progresses to affect proximal muscles. Almost all forms of distal myopathy can present as early as the second decade, although the onset is usually between 40 and 60 years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CONGENITAL MUSCULAR DYSTROPHIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term congenital muscular dystrophy (CMD) has been applied to infants who are hypotonic and weak at birth and have findings consistent with muscular dystrophy on muscle biopsy. Arthrogryposis (contracture of two or more joints at birth) is commonly observed in the newborn period.",
"   </p>",
"   <p>",
"    CMD is not a single entity. Rather, it includes a number of genetically determined conditions in which muscular dystrophy is evident at birth (",
"    <a class=\"graphic graphic_table graphicRef67132 \" href=\"mobipreview.htm?34/17/35101\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/21\">",
"     21",
"    </a>",
"    ]. Multiple genes have been associated with the various forms of CMD, including mutations in LAMA2, FKRP, LARGE, COL6A1, COL6A2, COL6A3, SEPN1, FCMD, POMGNT1, POMT1, POMT2, ITGA7, and LMNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. The serum CK concentration is usually elevated and muscle biopsy is characteristically abnormal with extensive fibrosis, degeneration and regeneration of muscle fibers and proliferation of fatty and connective tissue. In some cases, the clinical course is static but, in most patients, it progresses very slowly. However, actual improvement has been observed in a few cases.",
"   </p>",
"   <p>",
"    The original classification of the CMDs was based mainly upon the presence or absence of structural central nervous system abnormalities detected by neuroimaging or at autopsy (",
"    <a class=\"graphic graphic_table graphicRef54811 \" href=\"mobipreview.htm?29/27/30139\">",
"     table 3",
"    </a>",
"    ). The absence of structural changes distinguished \"occidental\" or \"classic\" CMD from \"syndromic\" forms of CMD such as Fukuyama muscular dystrophy, Walker-Warburg syndrome or muscle-eye-brain disease. However, the distinction is not entirely precise, as structural lesions have been described in some cases of classic CMD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/25\">",
"     25",
"    </a>",
"    ]. Cognitive impairment is a frequent manifestation of CMD, particularly in patients with structural brain lesions, although it has also been detected in patients with CMD and normal brain MRI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The syndromic CMDs are caused by defective post-translational modification of alpha-dystroglycan (dystroglycanopathies) and other proteins, and are caused by mutations in six different genes (LARGE, FKRP, FKTN, POMGNT1, POMT1, and POMT2). Dystroglycanopathies are characterized clinically by the involvement of multiple organ systems, severe brain malformations, and developmental delay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac involvement ranges from absent or mild to severe, and is most often associated with dystroglycanopathies such as Fukuyama type, Walker-Warburg syndrome, and muscle-eye-brain disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/28\">",
"     28",
"    </a>",
"    ]. Cardiac involvement is also seen in merosin-deficient CMD. In addition, cardiac involvement is a common manifestation of the congenital form of limb-girdle muscular dystrophy type 1B. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=see_link&amp;anchor=H6#H6\">",
"     \"Limb-girdle muscular dystrophy\", section on 'Autosomal recessive subtypes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Classic form",
"    </span>",
"    &nbsp;&mdash;&nbsp;The identification of mutations within the laminin alpha-2 chain gene (LAMA2; merosin) led to the subclassification of classic CMD into merosin-negative and merosin-positive groups. The chromosomal loci and the respective genes that have been identified for these disorders are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef67132 \" href=\"mobipreview.htm?34/17/35101\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Merosin-deficient CMD (MDC1A; MIM 607855), described in Caucasian children, is characterized by a combination of severe CMD, demyelination of the cerebral hemispheres (typically without structural CNS anomalies) and high CK levels. The associated mutated gene (LAMA2) was mapped to chromosome 6q22-23 and identified as encoding the alpha-2 chain of laminin, also known as merosin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/29\">",
"       29",
"      </a>",
"      ]. The laminin alpha-2 chain is a component of the DAP complex (",
"      <a class=\"graphic graphic_figure graphicRef66588 \" href=\"mobipreview.htm?3/48/3846\">",
"       figure 1",
"      </a>",
"      ). Staining of muscle biopsies from these patients with anti-merosin antibodies shows a diminished or absent pattern of the protein.",
"     </li>",
"     <li>",
"      Merosin-positive CMD without structural brain abnormalities usually has a milder phenotype. This group is clinically and genetically heterogeneous, and includes classic CMD without distinguishing features, rigid spine syndrome associated with mutations in the selenoprotein N1 gene (SEPN1), CMD with hyperextensible distal joints (Ullrich type), and CMD with mental retardation or sensory abnormalities (",
"      <a class=\"graphic graphic_table graphicRef54811 \" href=\"mobipreview.htm?29/27/30139\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef67132 \" href=\"mobipreview.htm?34/17/35101\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ullrich congenital muscular dystrophy and Bethlem myopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of multiple proximal joint contractures and hyperextensible distal joints in a child with congenital generalized weakness is suggestive of Ullrich congenital muscular dystrophy (MIM 254090). The course is characterized by a progressive decline in motor and respiratory function in the first decade of life, with a majority confined to wheelchair by 11 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/30\">",
"     30",
"    </a>",
"    ]. The phenotype was originally associated with recessive mutations in type VI collagen genes (COL6A1, COL6A2, and COL6A3), although dominant mutations were subsequently reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/31-36\">",
"     31-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations in the same genes also cause Bethlem myopathy (MIM 158810), a relatively mild disorder with proximal weakness and flexion contractures involving primarily distal joints (eg, ankles and interphalangeal joints of the fingers) but also involving the knees, hips, elbows, shoulders and neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Bethlem myopathy was originally associated with autosomal dominant mutations in COL6A1, COL6A2, and COL6A3 genes, but was later reported in two patients with compound heterozygous COL6A2 mutations and recessive inheritance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While Ullrich congenital muscular dystrophy and Bethlem myopathy were once believed to be separate entities, they are now considered to represent opposite ends of a phenotypic spectrum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/36\">",
"     36",
"    </a>",
"    ]. Genetic analysis of 49 patients with onset of symptoms during the first two years of life who had mutations in one of the COL6-encoding genes showed that homozygous stop-codon (nonsense) mutations in the triple helix domains resulted in the most severe phenotypes in which ambulation was never achieved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/40\">",
"     40",
"    </a>",
"    ]. In contrast, dominant de novo in-frame exon skipping and glycine missense mutations were associated with a moderate-progressive phenotype, characterized by loss of ambulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1689451\">",
"    <span class=\"h2\">",
"     Dystroglycanopathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dystroglycanopathies are associated with mutations in different genes that cause defective post-translational modification of alpha-dystroglycan (",
"    <a class=\"graphic graphic_figure graphicRef66588 \" href=\"mobipreview.htm?3/48/3846\">",
"     figure 1",
"    </a>",
"    ). They are both genetically and phenotypically heterogeneous. In current nomenclature, these phenotypes are referred to as the &ldquo;MDDG&rdquo; series and include mild to severe forms of congenital muscular dystrophy and mild forms of limb-girdle muscular dystrophy.",
"   </p>",
"   <p>",
"    Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A or MDDGA) includes the more severe phenotypes historically known as Walker-Warburg syndrome and Fukuyama congenital muscular dystrophy, and a milder phenotype called muscle-eye-brain disease. Subtypes of MDDGA are associated with specific mutations as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      MDDGA1, caused by a mutation in the POMT1 gene",
"     </li>",
"     <li>",
"      MDDGA2, caused by a mutation in the POMT2 gene",
"     </li>",
"     <li>",
"      MDDGA3, caused by a mutation in the POMGNT1 gene",
"     </li>",
"     <li>",
"      MDDGA4, caused by a mutation in the FKTN gene",
"     </li>",
"     <li>",
"      MDDGA5, caused by a mutation in the FKRP gene",
"     </li>",
"     <li>",
"      MDDGA6, caused by a mutation in the LARGE gene",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Congenital muscular dystrophy-dystroglycanopathy with or without mental retardation (type B or MDDGB) is also genetically heterogeneous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/23,41-47\">",
"     23,41-47",
"    </a>",
"    ] and follows a designation parallel to that of MDDGA:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      MDDGB1, caused by a mutation in the POMT1 gene",
"     </li>",
"     <li>",
"      MDDGB2, caused by a mutation in the POMT2 gene",
"     </li>",
"     <li>",
"      MDDGB3, caused by a mutation in the POMGNT1 gene",
"     </li>",
"     <li>",
"      MDDGB4, caused by a mutation in the FKTN gene",
"     </li>",
"     <li>",
"      MDDGB5, caused by a mutation in the FKRP gene",
"     </li>",
"     <li>",
"      MDDGB6, caused by a mutation in the LARGE gene",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The type B phenotypes of congenital muscular dystrophy-dystroglycanopathy are less severe than the type A but more severe than the type C (limb-girdle muscular dystrophy-dystroglycanopathy). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=see_link&amp;anchor=H4055140#H4055140\">",
"     \"Limb-girdle muscular dystrophy\", section on 'Dystroglycanopathies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The phenotypes of congenital muscular dystrophy-dystroglycanopathy historically designated as Fukuyama, Walker-Warburg, and muscle-eye-brain disease (all now considered type A) are reviewed in the sections that follow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Fukuyama type",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Fukuyama type of CMD (MIM 253800) is among the most common autosomal recessive disorders in Japan (0.7 to 1.2 per 10,000 births) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/48\">",
"     48",
"    </a>",
"    ], and is characterized by hypotonia, generalized weakness, severe developmental delay, seizures, microcephaly, and elevated serum CK levels (",
"    <a class=\"graphic graphic_table graphicRef54811 \" href=\"mobipreview.htm?29/27/30139\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The electroencephalogram is abnormal in this disorder and shows epileptiform activity. Cortical dysgenesis is detected by cerebral CT or MRI. The specific lesions are pachygyria and polymicrogyria in the temporal and occipital regions. Transient T2 hyperintensities appear in the white matter, and hypoplasia of the pons and cerebellar cysts may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/50\">",
"     50",
"    </a>",
"    ]. Ocular involvement is limited to simple myopia without structural changes.",
"   </p>",
"   <p>",
"    The locus for the mutated Fukuyama-type (MDDGA4) congenital muscular dystrophy gene (FKTN gene) is located on chromosome 9q31-33 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/48,51\">",
"     48,51",
"    </a>",
"    ]. The respective protein, fukutin, is secreted outside the cell and may be a component of the extracellular matrix reinforcing muscle membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/50\">",
"     50",
"    </a>",
"    ]. Pathologic studies of the brain have suggested that fukutin is a constituent of the basement membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    FKTN mutations have also been associated with severe dilated cardiomyopathy accompanied by a mild form of limb-girdle muscular dystrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/53\">",
"     53",
"    </a>",
"    ]. In addition, FKTN gene mutations have been identified in children with an LGMD phenotype and normal intelligence and brain structure designated muscular dystrophy-dystroglycanopathy (limb-girdle) type C4 (MDDGC4). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=see_link\">",
"     \"Limb-girdle muscular dystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1689415\">",
"    <span class=\"h3\">",
"     Walker-Warburg syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebro-ocular dysplasia or Walker-Warburg syndrome is a type of CMD associated with ocular dysplasia, hydrocephalus, and cerebral malformations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/54\">",
"     54",
"    </a>",
"    ]. Ocular abnormalities include cataracts, optic nerve hypoplasia, corneal clouding and retinal dysplasia or detachment. Serum CK concentration is mildly to moderately elevated in this disorder and the electrodiagnostic findings are myopathic. Brain MRI shows hypodense white matter, hypoplastic cerebellum and pons, ventricular dilatation (with or without hydrocephalus) and abnormal cortical development known as cobblestone type brain malformation (also called Type II lissencephaly). Other malformations include Dandy-Walker cyst, sometimes associated with posterior encephaloceles. The median survival is only four months.",
"   </p>",
"   <p>",
"    The Walker-Warburg phenotype is associated with mutations in the POMT1, POMT2, FKTN, FKRP, POMGNT1, LARGE, ISPD, and GTDC2 genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/41,42,55-65\">",
"     41,42,55-65",
"    </a>",
"    ]. These mutations cause defective glycosylation of alpha-dystroglycan complex (",
"    <a class=\"graphic graphic_figure graphicRef66588 \" href=\"mobipreview.htm?3/48/3846\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/57\">",
"     57",
"    </a>",
"    ]. In current terminology (",
"    <a class=\"graphic graphic_table graphicRef67132 \" href=\"mobipreview.htm?34/17/35101\">",
"     table 2",
"    </a>",
"    ), Walker-Warburg syndrome associated with POMT1 mutations (MIM 236670) is designated as muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A1 (MDDGA1).",
"   </p>",
"   <p>",
"    Other mutations in the POMT1 gene are linked to a milder phenotype of congenital muscular dystrophy with microcephaly and mental retardation, but without the ocular manifestations or structural brain malformations of WWS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/66\">",
"     66",
"    </a>",
"    ]. In addition, POMT1 and POMT2 gene mutations have been identified in children with subtypes of autosomal recessive limb-girdle muscular dystrophy (MDDGC1 and MDDGC2). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=see_link&amp;anchor=H6#H6\">",
"     \"Limb-girdle muscular dystrophy\", section on 'Autosomal recessive subtypes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Muscle-eye-brain disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle-eye-brain (MEB) disease has a milder phenotype than WWS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/67\">",
"     67",
"    </a>",
"    ]. The disorder is especially prevalent in Finland.",
"   </p>",
"   <p>",
"    Patients with MEB typically present with hypotonia, severe progressive myopia from infancy, and developmental delay. Pale retina, low or flat electroretinogram, and visual failure related to retinal degeneration develop with advancing age. Seizures are common and cognitive impairment is often severe. At approximately five years of age, most patients decline motorically and develop contractures and spasticity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory findings in MEB disease include an elevated serum CPK level. Electromyography shows myopathic findings and the electroencephalogram is always abnormal. Brain MRI shows cobblestone lissencephaly, although it is less severe than in WWS; the brainstem in MEB disease is characteristically flat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/69\">",
"     69",
"    </a>",
"    ]. Ventriculomegaly and white matter hypodensities may also be seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/70\">",
"     70",
"    </a>",
"    ]. Visual evoked potentials are delayed and giant (&gt;50 &micro;v) in most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Muscle biopsy usually shows dystrophic changes, although these may be minimal. Immunohistochemistry shows normal dystrophin and other dystrophin-associated proteins except for deficient alpha-dystroglycan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical phenotype of MEB can be caused by gene mutations of POMGNT1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/72-75\">",
"     72-75",
"    </a>",
"    ], FKRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/60\">",
"     60",
"    </a>",
"    ], POMT2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/42,76\">",
"     42,76",
"    </a>",
"    ], POMT1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/23\">",
"     23",
"    </a>",
"    ], FKTN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/77\">",
"     77",
"    </a>",
"    ], and LARGE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/43\">",
"     43",
"    </a>",
"    ]. In current terminology (",
"    <a class=\"graphic graphic_table graphicRef67132 \" href=\"mobipreview.htm?34/17/35101\">",
"     table 2",
"    </a>",
"    ), POMGNT1-related muscle-eye-brain disease (MIM 253280) is designated as muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A3 (MDDGA3).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The infant with any type of CMD typically presents in the newborn period as a floppy baby, often with arthrogryposis. The clinical features are similar to those of an infant with a severe congenital myopathy, a disorder that is more frequent than the rare congenital muscular dystrophies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34004?source=see_link\">",
"     \"Approach to the infant with hypotonia and weakness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/6/13417?source=see_link\">",
"     \"Congenital myopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI of the brain is useful to look for structural lesions or white matter abnormalities that accompany some CMDs. Examination of the eyes is important to exclude an ocular abnormality. The infant with a CMD has variably elevated serum CK levels.",
"   </p>",
"   <p>",
"    Molecular genetic testing allows for confirmation of some forms of CMD, including those associated with mutations in LAMA2, SEPN1,",
"    <span class=\"nowrap\">",
"     COL6A1/A2/A3,",
"    </span>",
"    FKRP, POMT1, POMT2, FKTN, POMGNT1, and LARGE1. The diagnosis can also be confirmed by muscle biopsy findings of wide-spread dystrophic changes or a myopathic pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/78\">",
"     78",
"    </a>",
"    ]. In infants lacking merosin, muscle immunohistochemical examination with antimerosin antibodies usually reveals an absence of this protein in the sarcolemma of the muscle fibers.",
"   </p>",
"   <p>",
"    For patients with a clinical presentation that suspicion for CMD, we suggest an evaluation that includes cranial MRI, eye examination, and DNA testing. A muscle biopsy for histology and immunostaining is indicated if the molecular genetic testing is negative, but muscle biopsy is not needed if a compatible mutation is identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;No definitive treatment is available for these disorders. General management principles include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41192/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measures to control weight and avoid obesity",
"     </li>",
"     <li>",
"      Physical therapy to improve mobility and avoid contractures",
"     </li>",
"     <li>",
"      Mechanical assistive devices to increase mobility and ambulation",
"     </li>",
"     <li>",
"      Surgery for orthopedic complications",
"     </li>",
"     <li>",
"      Monitoring of pulmonary function and, when beneficial, use of assisted cough, noninvasive ventilation, or tracheostomy and mechanical ventilation",
"     </li>",
"     <li>",
"      Cardiac evaluation at diagnosis for all infants with CMD and routine monitoring for those with or at risk for cardiac involvement",
"     </li>",
"     <li>",
"      Social and emotional support",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/13/34001?source=see_link\">",
"       \"Patient information: Muscular dystrophy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/33/32276?source=see_link\">",
"       \"Patient information: Overview of muscular dystrophies (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/1\">",
"      VICTOR M, HAYES R, ADAMS RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N Engl J Med 1962; 267:1267.",
"     </a>",
"    </li>",
"    <li>",
"     Brais B, Rouleau GA. Oculopharyngeal muscular dystrophy. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1126/ (Accessed on February 15, 2011).",
"    </li>",
"    <li>",
"     Barbeau A. The symptom of hereditary late-onset ptosis and dysphagia in French-Canada. In: Symposium uber progressive muskeldystrophie, Kuhn E (Ed), Springer-Verlag, Berlin 1966. p.102.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/4\">",
"      Blumen SC, Nisipeanu P, Sadeh M, et al. Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord 1997; 7 Suppl 1:S38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/5\">",
"      Blumen SC, Korczyn AD, Lavoie H, et al. Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology 2000; 55:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/6\">",
"      Grewal RP, Karkera JD, Grewal RK, Detera-Wadleigh SD. Mutation analysis of oculopharyngeal muscular dystrophy in Hispanic American families. Arch Neurol 1999; 56:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/7\">",
"      Becher MW, Morrison L, Davis LE, et al. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 2001; 286:2437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/8\">",
"      Brais B. Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep 2009; 9:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/9\">",
"      Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998; 18:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/10\">",
"      Calado A, Tom&eacute; FM, Brais B, et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 2000; 9:2321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/11\">",
"      Blumen SC, Brais B, Korczyn AD, et al. Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol 1999; 46:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/12\">",
"      Blumen SC, Bouchard JP, Brais B, et al. Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology 2009; 73:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/13\">",
"      Duranceau A. Cricopharyngeal myotomy in the management of neurogenic and muscular dysphagia. Neuromuscul Disord 1997; 7 Suppl 1:S85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/14\">",
"      Davies JE, Wang L, Garcia-Oroz L, et al. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 2005; 11:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/15\">",
"      Davies JE, Rose C, Sarkar S, Rubinsztein DC. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy. Sci Transl Med 2010; 2:34ra40.",
"     </a>",
"    </li>",
"    <li>",
"     Orrell, RW, Darras, BT, Griggs, RC. Facioscapulohumeral dystrophy, scapuloperoneal syndromes, and distal myopathies. In: Neuromuscular disorders in infancy, childhood, and adolescence: A clinician's approach, Jones, HR, De Vivo, DC, Darras, BT (Eds), Butterworth Heinemann, Philadelphia 2003. p.701.",
"    </li>",
"    <li>",
"     Suominen T, Udd B, Hackman P. Udd distal myopathy. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1323/ (Accessed on January 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/18\">",
"      Guergueltcheva V, Peeters K, Baets J, et al. Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency. Neurology 2011; 77:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/19\">",
"      Schessl J, Kress W, Schoser B. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy. Muscle Nerve 2012; 45:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/20\">",
"      Bolduc V, Marlow G, Boycott KM, et al. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 2010; 86:213.",
"     </a>",
"    </li>",
"    <li>",
"     Sparks S, Quijano-Roy S, Harper A, et al. Congenital muscular dystrophy overview. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1291/ (Accessed on September 05, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/22\">",
"      Quijano-Roy S, Mbieleu B, B&ouml;nnemann CG, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 2008; 64:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/23\">",
"      Mercuri E, Messina S, Bruno C, et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology 2009; 72:1802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/24\">",
"      Mercuri E, Muntoni F. The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol 2012; 72:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/25\">",
"      Pini A, Merlini L, Tom&eacute; FM, et al. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain Dev 1996; 18:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/26\">",
"      Messina S, Bruno C, Moroni I, et al. Congenital muscular dystrophies with cognitive impairment. A population study. Neurology 2010; 75:898.",
"     </a>",
"    </li>",
"    <li>",
"     Gordon E, Hoffman EP, Pegoraro E. Congenital muscular dystrophy overview. www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=cmd-overview (Accessed on September 20, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/28\">",
"      Finsterer J, Ramaciotti C, Wang CH, et al. Cardiac findings in congenital muscular dystrophies. Pediatrics 2010; 126:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/29\">",
"      Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/30\">",
"      Nadeau A, Kinali M, Main M, et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009; 73:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/31\">",
"      Camacho Vanegas O, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A 2001; 98:7516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/32\">",
"      Demir E, Sabatelli P, Allamand V, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002; 70:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/33\">",
"      Pan TC, Zhang RZ, Sudano DG, et al. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003; 73:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/34\">",
"      Baker NL, M&ouml;rgelin M, Peat R, et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005; 14:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/35\">",
"      Giusti B, Lucarini L, Pietroni V, et al. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy. Ann Neurol 2005; 58:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/36\">",
"      Lampe AK, Bushby KM. Collagen VI related muscle disorders. J Med Genet 2005; 42:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/37\">",
"      Bethlem J, Wijngaarden GK. Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees. Brain 1976; 99:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/38\">",
"      Baker NL, M&ouml;rgelin M, Pace RA, et al. Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Ann Neurol 2007; 62:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/39\">",
"      Gualandi F, Urciuolo A, Martoni E, et al. Autosomal recessive Bethlem myopathy. Neurology 2009; 73:1883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/40\">",
"      Bri&ntilde;as L, Richard P, Quijano-Roy S, et al. Early onset collagen VI myopathies: Genetic and clinical correlations. Ann Neurol 2010; 68:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/41\">",
"      Yanagisawa A, Bouchet C, Van den Bergh PY, et al. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation. Neurology 2007; 69:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/42\">",
"      Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007; 130:2725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/43\">",
"      Clement E, Mercuri E, Godfrey C, et al. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008; 64:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/44\">",
"      Villanova M, Mercuri E, Bertini E, et al. Congenital muscular dystrophy associated with calf hypertrophy, microcephaly and severe mental retardation in three Italian families: evidence for a novel CMD syndrome. Neuromuscul Disord 2000; 10:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/45\">",
"      Brockington M, Blake DJ, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001; 69:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/46\">",
"      Mercuri E, Topaloglu H, Brockington M, et al. Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol 2006; 63:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/47\">",
"      Longman C, Brockington M, Torelli S, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 2003; 12:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/48\">",
"      Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998; 394:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/49\">",
"      Kamoshita S, Konishi Y, Segawa M, Fukuyama Y. Congenital muscular dystrophy as a disease of the central nervous system. Arch Neurol 1976; 33:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/50\">",
"      Toda T, Kobayashi K, Kondo-Iida E, et al. The Fukuyama congenital muscular dystrophy story. Neuromuscul Disord 2000; 10:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/51\">",
"      Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1993; 5:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/52\">",
"      Yamamoto T, Shibata N, Kanazawa M, et al. Early ultrastructural changes in the central nervous system in Fukuyama congenital muscular dystrophy. Ultrastruct Pathol 1997; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/53\">",
"      Murakami T, Hayashi YK, Noguchi S, et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 2006; 60:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/54\">",
"      Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989; 32:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/55\">",
"      Beltr&aacute;n-Valero de Bernab&eacute; D, Currier S, Steinbrecher A, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002; 71:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/56\">",
"      van Reeuwijk J, Janssen M, van den Elzen C, et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005; 42:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/57\">",
"      van Reeuwijk J, Brunner HG, van Bokhoven H. Glyc-O-genetics of Walker-Warburg syndrome. Clin Genet 2005; 67:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/58\">",
"      de Bernab&eacute; DB, van Bokhoven H, van Beusekom E, et al. A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. J Med Genet 2003; 40:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/59\">",
"      Silan F, Yoshioka M, Kobayashi K, et al. A new mutation of the fukutin gene in a non-Japanese patient. Ann Neurol 2003; 53:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/60\">",
"      Beltran-Valero de Bernab&eacute; D, Voit T, Longman C, et al. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet 2004; 41:e61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/61\">",
"      Clement EM, Godfrey C, Tan J, et al. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol 2008; 65:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/62\">",
"      van Reeuwijk J, Grewal PK, Salih MA, et al. Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum Genet 2007; 121:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/63\">",
"      Willer T, Lee H, Lommel M, et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet 2012; 44:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/64\">",
"      Roscioli T, Kamsteeg EJ, Buysse K, et al. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of &alpha;-dystroglycan. Nat Genet 2012; 44:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/65\">",
"      Manzini MC, Tambunan DE, Hill RS, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet 2012; 91:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/66\">",
"      D'Amico A, Tessa A, Bruno C, et al. Expanding the clinical spectrum of POMT1 phenotype. Neurology 2006; 66:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/67\">",
"      Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev 1989; 11:147.",
"     </a>",
"    </li>",
"    <li>",
"     Jones K, North K. The congenital muscular dystrophies. In: Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach, Jones HR, De Vivo DC, Darras BT (Eds), Butterworth-Heinemann, Philadelphia 2003. p.633.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/69\">",
"      Haltia M, Leivo I, Somer H, et al. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 1997; 41:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/70\">",
"      Valanne L, Pihko H, Katevuo K, et al. MRI of the brain in muscle-eye-brain (MEB) disease. Neuroradiology 1994; 36:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/71\">",
"      Kano H, Kobayashi K, Herrmann R, et al. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 2002; 291:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/72\">",
"      Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/73\">",
"      Taniguchi K, Kobayashi K, Saito K, et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum Mol Genet 2003; 12:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/74\">",
"      Vervoort VS, Holden KR, Ukadike KC, et al. POMGnT1 gene alterations in a family with neurological abnormalities. Ann Neurol 2004; 56:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/75\">",
"      Cormand B, Avela K, Pihko H, et al. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am J Hum Genet 1999; 64:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/76\">",
"      Yanagisawa A, Bouchet C, Quijano-Roy S, et al. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. Eur J Med Genet 2009; 52:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/77\">",
"      Vuillaumier-Barrot S, Quijano-Roy S, Bouchet-Seraphin C, et al. Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype. Neuromuscul Disord 2009; 19:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41192/abstract/78\">",
"      Peat RA, Smith JM, Compton AG, et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology 2008; 71:312.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6180 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.22.229.50-9BE3393297-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41192=[""].join("\n");
var outline_f40_14_41192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OCULOPHARYNGEAL MUSCULAR DYSTROPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DISTAL MUSCULAR DYSTROPHIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CONGENITAL MUSCULAR DYSTROPHIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Classic form",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ullrich congenital muscular dystrophy and Bethlem myopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1689451\">",
"      Dystroglycanopathies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Fukuyama type",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1689415\">",
"      - Walker-Warburg syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Muscle-eye-brain disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6180\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6180|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/48/3846\" title=\"figure 1\">",
"      Dystrophin associated protein",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6180|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/23/7550\" title=\"table 1\">",
"      Distal muscular dystrophies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/17/35101\" title=\"table 2\">",
"      Genetic classification of CMD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/27/30139\" title=\"table 3\">",
"      Historical classification of CMD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34004?source=related_link\">",
"      Approach to the infant with hypotonia and weakness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/56/905?source=related_link\">",
"      Approach to the metabolic myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/16/1290?source=related_link\">",
"      Clinical features and diagnosis of Duchenne and Becker muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/6/13417?source=related_link\">",
"      Congenital myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21415?source=related_link\">",
"      Emery-Dreifuss muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/34/26153?source=related_link\">",
"      Facioscapulohumeral muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15881?source=related_link\">",
"      Limb-girdle muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/26/19882?source=related_link\">",
"      Myotonic dystrophy: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/13/34001?source=related_link\">",
"      Patient information: Muscular dystrophy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/33/32276?source=related_link\">",
"      Patient information: Overview of muscular dystrophies (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41193="Group A streptococcus: Virulence factors and pathogenic mechanisms";
var content_f40_14_41193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Group A streptococcus: Virulence factors and pathogenic mechanisms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Dennis L Stevens, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Amy Bryant, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/14/41193/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/14/41193/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group A streptococci (GAS), also known as Streptococcus pyogenes, causes a wide range of infections and complications. Over recent decades in the western world, streptococcal pharyngitis, erysipelas, and scarlet fever have become milder diseases, and the prevalence of acute rheumatic fever and poststreptococcal glomerulonephritis have reached all time lows. During the same time period, severe invasive infections such as necrotizing fasciitis and streptococcal toxic shock syndrome have increased in prevalence worldwide.",
"   </p>",
"   <p>",
"    Since 1985, several epidemics of rheumatic fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/1\">",
"     1",
"    </a>",
"    ] and severe invasive GAS infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/2\">",
"     2",
"    </a>",
"    ] have been described from many sites around the world. The prevalence of streptococcal infections of all types remains high in developing countries. In addition, streptococcal pharyngitis remains a common infection in western countries.",
"   </p>",
"   <p>",
"    The interaction between the host and this important pathogen will be reviewed here. The wide variety of GAS infections are discussed separately in the appropriate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Streptococcus pyogenes, or GAS, is a facultative, gram-positive coccus that grows in chains and causes numerous infections in humans including pharyngitis, tonsillitis, scarlet fever, cellulitis, erysipelas, rheumatic fever, poststreptococcal glomerulonephritis, necrotizing fasciitis, toxic shock syndrome, myonecrosis, and lymphangitis. The only known reservoir for GAS in nature is the skin and mucous membranes of the human host. While the clinical diseases produced by GAS have been well described, the pathogenic mechanisms underlying these infections are poorly understood, largely because each is the culmination of highly complex interactions between the human host defense mechanisms and specific virulence factors of the streptococcus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MICROBIOLOGIC CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;GAS require complex media containing blood products, grow best in an environment of 10 percent carbon dioxide and produce pinpoint colonies on blood agar plates, which are surrounded by a zone of complete (beta) hemolysis. The exhaustive work of Rebecca Lancefield established the classification of streptococci into types A through O based upon acid extractable carbohydrate antigens of cell wall material [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ]. GAS has also been subdivided based upon the surface expression of M and T antigens. Subtyping strains of GAS has proven invaluable for epidemiological studies, in much the same way that phage typing has been useful to define the epidemiology of Staphylococcus aureus. High resolution genotyping provides a more specific determination of relatedness among strains isolated from outbreaks of GAS infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/4\">",
"     4",
"    </a>",
"    ]. Finally rapid, sequencing of the gene encoding M-protein is providing a rapid definitive way of comparing M-typeable and M-non-typeable strains.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     VIRULENCE FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of different constituents and products of GAS have been identified as virulence factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Capsule",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some strains of S. pyogenes possess thick capsules of hyaluronic acid resulting in large mucoid colonies on blood agar. Luxuriant production of M-protein may also impart a mucoid colony morphology, a trait that has been associated most commonly with M-18 strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/5\">",
"     5",
"    </a>",
"    ]. Utilizing an isogenic mutant of an M-18 strain, investigators showed that the strains producing hyaluronic acid capsule were resistant to phagocytosis and were virulent in mice, whereas the hyaluronic acid deficient strain was non-virulent and readily killed by phagocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/6\">",
"     6",
"    </a>",
"    ]. Interestingly, the non-hyaluronic acid producing strain adhered to macrophages with greater avidity than the mucoid strain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/6\">",
"     6",
"    </a>",
"    ]. This suggests that hyaluronic acid capsule, like M-protein confers resistance to phagocytosis but that such capsules also interfere with adherence to eukaryotic cells. Streptococci possessing hyaluronic acid capsule adhere to keratinocytes through specific receptors (CD44) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cell wall",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cell wall is comprised of a peptidoglycan backbone with integral lipoteichoic acid components. The main function of these components is structural stability of the microbe, though the exact function of lipoteichoic acid is unknown. Lipoteichoic acid may play a role in pathogenesis by facilitating the adherence of GAS to pharyngeal epithelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/10\">",
"     10",
"    </a>",
"    ]. Peptidoglycan, like endotoxin from gram-negative bacteria, is capable of activating the alternative complement pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     M-proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 80 different M-protein types of GAS are currently described. The emm gene encodes the M protein, a coiled-coil consisting of four regions of repeating amino acids (A-D), a",
"    <span class=\"nowrap\">",
"     proline/glycine",
"    </span>",
"    rich region, which serves to intercalate the protein into the bacterial cell wall, and a hydrophobic region, which acts as a membrane anchor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/13\">",
"     13",
"    </a>",
"    ]. Region A near the N-terminus is highly variable, and antibodies to this region confer type-specific protection. Within the more conserved B-D regions lies an area which binds one of the complement regulatory proteins (factor H), sterically inhibiting antibody binding and complement-derived opsonin deposition, and effectively camouflaging the organism against humoral immune surveillance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/14\">",
"     14",
"    </a>",
"    ]. M-protein also protects the organism against phagocytosis by polymorphonuclear leukocytes (PMNs) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/15\">",
"     15",
"    </a>",
"    ], although this property can be overcome by type-specific antisera [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3,13,16\">",
"     3,13,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observations by Lancefield suggested that the quantity of M-protein produced decreases with passage on artificial media but increases rapidly with passage through mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ]. In humans, the quantity of M-protein produced by an infecting strain progressively decreases during convalescence and with prolonged carriage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Non-typeable strains of GAS may express minute amounts of M-protein, express a totally new M-type that is not reflected in the current typing protocols, or may lack M-protein altogether. As an example, 60 non-typeable strains, which had been isolated from upper respiratory sources in southeast Asia, were found to be resistant to phagocytosis in normal serum or plasma, suggesting that these strains do in fact produce M-protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/17\">",
"     17",
"    </a>",
"    ]. These data are compatible with the view that new M-types are constantly emerging. This could result from mutational events within the emm gene, producing novel M-proteins that no longer cross-react with standard polyvalent typing sera. Evidence that heterogeneity within this gene locus does in fact occur has been demonstrated among strains typed as M-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/18\">",
"     18",
"    </a>",
"    ]. In subsequent studies by these investigators, roughly 50 percent of randomly collected human sera opsonized seven strains of M-1 GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/19\">",
"     19",
"    </a>",
"    ]. In contrast, the remaining 50 percent of serum samples opsonized only some of these strains, prompting the authors to conclude that opsonic antibody may not be type-specific, but rather strain specific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The problems with serologic typing of the surface M proteins with available polyclonal sera, created a need for an alternate means of M type deduction. In one study, investigators designed primer pairs that allowed amplification by polymerase chain reaction (PCR) of the emm genes of all available M-type reference strains and 74 clinical isolates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/20\">",
"     20",
"    </a>",
"    ]. Sequence analysis of specific PCR products was used to accurately deduce emm types corresponding to the majority of the known M serotypes. This was possible because the highly variable N-terminus of the M protein (see above) correlates with a variable 5' region of the emm gene that confers distinguishable M serotypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Vaccine implications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typing of emm genes has important implications for GAS virulence and vaccine development. In one report of 5400 cases of invasive GAS infection, emm types 1, 3 and 12 were independent risk factors associated with mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/21\">",
"     21",
"    </a>",
"    ]. The emm serotypes in a proposed 26-valent vaccine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/22,23\">",
"     22,23",
"    </a>",
"    ] accounted for 79 percent of isolates, for 85 and 88 percent of isolates implicated in necrotizing fasciitis and staphylococcus toxic shock syndrome, respectively, and for 79 percent of deaths.",
"   </p>",
"   <p>",
"    The authors calculated that the proposed vaccine could prevent up to 50 and 63 percent of invasive GAS infections among the elderly and children, respectively. However, the distribution of these M types may not be uniform in all regions, and serotypes may shift over time, as has been observed with the pneumococcal conjugate vaccine&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/24-26\">",
"     24-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiologic observation that pharyngitis is less frequent in adults compared with children suggests that immunity to GAS does occur; it is unclear whether an immune response is mounted against specific M-proteins or also to other antigens produced by GAS strains.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Immunoglobulin binding M-like proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;GAS produce a family of proteins which share structural similarities to M-proteins and also bind immunoglobulins including IgG, IgM, and IgA. Unlike M-protein, these molecules do not inhibit phagocytosis in the absence of type-specific antibody. Nonetheless, these molecules, like M-protein, may play a role in pathogenesis by interfering with complement activation. One study supported this hypothesis by nicely demonstrating that IgG binding protein from GAS selectively bound C4b binding protein (C4BP), a protein that is intimately involved in the regulation of the complement system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/27\">",
"     27",
"    </a>",
"    ]. The authors concluded that this protein might interfere with opsonization by down regulating complement activation, but acknowledged that it could also serve as a ligand between GAS and host cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/27\">",
"     27",
"    </a>",
"    ] and thus might actually facilitate non-immune phagocytosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Fibronectin binding protein (protein F)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Binding of GAS to fibronectin appears to enhance the adherence of GAS to epithelial surfaces. One group described protein F, a 659 amino acid protein with two fibronectin binding domains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/28\">",
"     28",
"    </a>",
"    ]. It was suggested that Protein F might be found in abundance in isolates from patients with invasive GAS infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/29\">",
"     29",
"    </a>",
"    ]. Yet studies which defined the distribution of Protein F among various M-types indicated that M-types 1 and 3, the two most common strains isolated from patients with invasive GAS infections, did not produce Protein F [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/29\">",
"     29",
"    </a>",
"    ]. These authors were able to demonstrate that high carbon dioxide concentrations increase the expression of Protein F. Thus, protein F or perhaps other fibronectin binding proteins might play an important role in the adhesion of GAS to mucosal or skin surfaces.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Vimentin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vimentin was identified as the major skeletal-muscle GAS-binding protein in an in vitro model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/30\">",
"     30",
"    </a>",
"    ]. Vimentin expression was found to be up-regulated on injured skeletal muscle cells in vitro and was expressed in muscle tissues from a patient with GAS myonecrosis who died of GAS toxic shock syndrome. These findings may provide a molecular explanation to the development of severe GAS soft tissue infection in patients without an obvious portal of infection but with minor muscle trauma. This may also explain why GAS localizes to the exact site of muscle injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Streptococcal inhibitor of complement",
"    </span>",
"    &nbsp;&mdash;&nbsp;A novel extracellular protein of 305 amino acid residues, called streptococcal inhibitor of complement (SIC), inactivates the complement membrane attack complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/31\">",
"     31",
"    </a>",
"    ]. SIC is found only in M types 1 and 57. The sic gene is located in the mga regulon of M-type 1 GAS, directly adjacent to the emm gene.",
"   </p>",
"   <p>",
"    Through the production of SIC, GAS could evade destruction by the membrane attack complex (C5-C9) generated by either the alternative or classical complement pathway. SIC can also inhibit the antibacterial activity of chemokines that are part of innate immunity against GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Role in innate immunity'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Opacity factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The opacity factor (OF) has been found largely in GAS but has also been detected in Group G and C streptococci, S. dysgalactiae, and S. equisimilis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/33\">",
"     33",
"    </a>",
"    ]. OF is a type-specific lipoprotein lipase whose role in pathogenesis is unknown. There is evidence to suggest that the presence of OF relates to the arrangement of specific emm genes. Specifically, OF is associated with M-types that are largely skin strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Streptolysin O",
"    </span>",
"    &nbsp;&mdash;&nbsp;Streptolysin O belongs to a family of oxygen-labile, thiol-activated cytolysins, which causes the broad zone of beta-hemolysis surrounding colonies of S. pyogenes on blood agar plates (",
"    <a class=\"graphic graphic_picture graphicRef68908 \" href=\"mobipreview.htm?15/33/15903\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/35\">",
"     35",
"    </a>",
"    ]. The zone of hemolysis is enhanced by stabbing the inoculum into the bottom of the culture media. Thiol-activated cytolysins bind to cholesterol on eukaryotic cell membranes creating toxin-cholesterol aggregates that contribute to cell lysis via a colloid-osmotic mechanism. Cholesterol inhibits both toxicity in isolated myocytes and hemolysis of red blood cells in vitro. In situations where serum cholesterol is high (ie, nephrotic syndrome), falsely elevated anti-streptolysin O (ASO) titers may occur because both cholesterol and anti-ASO antibody will \"neutralize streptolysin O\" (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33430?source=see_link\">",
"     \"Lipid abnormalities in nephrotic syndrome\"",
"    </a>",
"    ). Striking amino acid homology exists between streptolysin O and thiol-activated cytolysins from other gram-positive bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anti-streptolysin O (ASO) titers vary with age, season, and geography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/37\">",
"     37",
"    </a>",
"    ]. Healthy children of elementary school age commonly have titers of 200 to 300 Todd units per mL; asymptomatic pharyngeal strep carriers tend to have very low titers, just above detectable. Following streptococcal pharyngitis, the antibody response peaks at about four to five weeks, which usually is during the second or third week of rheumatic fever. Antibody titers fall off rapidly in the next several months and after six months have a slower decline. For these reasons, it may be useful to collect one specimen when the diagnosis of ARF is first suspected and another two weeks later.",
"   </p>",
"   <p>",
"    About 80 percent of patients with documented ARF demonstrate a rise in antistreptolysin titer, although this cannot be used as a measure of rheumatic activity. A negative antistreptolysin titer should prompt testing for other antistreptococcal antibodies such as anti-DNAse B (detectable for six to nine months following infection), streptokinase, and antihyaluronidase; commercial tests for these antibodies are available. About 90 percent of patients with documented ARF have positive findings if two antigens are evaluated; about 95 percent have positive findings if three antigens are evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Streptolysin S",
"    </span>",
"    &nbsp;&mdash;&nbsp;Streptolysin S is a cell-associated hemolysin that does not diffuse into the agar media. Purification and characterization of this protein has been difficult, and its only role in pathogenesis may be through direct, contact dependent, cytotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Deoxyribonucleases A, B, C, and D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expression of deoxyribonucleases (DNases) in vivo, especially DNase B, elicits production of anti-DNase antibody following either pharyngeal or skin infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=see_link&amp;anchor=H14578038#H14578038\">",
"     \"Differential diagnosis and evaluation of glomerular disease\", section on 'Hematuria following upper respiratory infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hyaluronidase",
"    </span>",
"    &nbsp;&mdash;&nbsp;This extracellular enzyme hydrolyzes hyaluronic acid in deeper tissues and may facilitate the spread of infection along fascial planes. Anti-hyaluronidase titers rise following S. pyogenes infections, especially those infections involving the skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nicotine-adenine-dinucleotidase (NADase)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This extracellular enzyme also called NAD glycohydrolase has been produced by many strains of GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/39\">",
"     39",
"    </a>",
"    ]. It is not known what function this enzyme serves for the organism, and it is also unclear what role NADase may play in pathogenesis of any GAS infection. NADase has been shown to be expressed in M-1 and M-3 strains of GAS but not in non-invasive strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/40\">",
"     40",
"    </a>",
"    ]. Among contemporary strains there is an excellent correlation between NADase production and the ability of strains to cause invasive infection. Interestingly, in a survey done 20 years ago, NADase was not found in M-1 strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Streptokinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Streptokinase is produced by all strains of GAS and is located in the extracellular milieu. In contrast, a plasminogen binding site is found on the surface of strains of GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/41\">",
"     41",
"    </a>",
"    ]. Once plasminogen is bound, streptokinase proteolytically converts bound plasminogen to active plasmin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/41\">",
"     41",
"    </a>",
"    ]. Plasmin then cleaves fibrin into fragments known as fibrin degradation produces. Bound plasmin cannot be inhibited by endogenous anti-proteases such as alpha-l anti-trypsin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/41\">",
"     41",
"    </a>",
"    ]. The role of streptokinase in GAS infections is unclear, although it may play a role in poststreptococcal glomerulonephritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cell envelope proteinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lethal necrotizing fasciitis caused by S. pyogenes is characterized by a lack of neutrophils at the site of infection. Interleukin (IL)-8, which is important for neutrophil transmigration and activation, can be degraded by S. pyogenes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/42\">",
"     42",
"    </a>",
"    ]. The IL-8 cleaving activity corresponded with the presence of S. pyogenes cell envelope proteinase (SpyCPE) in the supernatant. Cleavage of IL-8, preventing neutrophil recruitment, represents a novel mechanism of immune evasion by S. pyogenes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pyrogenic exotoxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Streptococcal pyrogenic exotoxins (SPE) type A, B, and C, also called scarlatina or erythrogenic toxins, induce lymphocyte blastogenesis, potentiate endotoxin-induced shock, induce fever, suppress antibody synthesis, and act as superantigens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/43\">",
"     43",
"    </a>",
"    ]. The identification of these three different types of pyrogenic exotoxins may partially explain why some individuals have multiple attacks of scarlet fever. The genes for pyrogenic exotoxins A (speA) and C (speC) are transmitted by bacteriophage, and stable production depends upon lysogenic conversion in a manner analogous to toxin production by Corynebacterium diphtheriae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Control of SPEA production is not yet understood. However, this mechanism is likely to be important since it is well established that the quantity of streptococcal pyrogenic exotoxin A produced by strains varies dramatically from decade to decade. In addition, point mutations in the speA gene result in dramatic changes in the potency of SPEA toxin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/45\">",
"     45",
"    </a>",
"    ]. Historically, streptococcal pyrogenic exotoxin A and B-producing strains have been associated with severe cases of scarlet fever and more recently, with streptococcal toxic shock syndrome (TSS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6616?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although all strains of GAS are endowed with the gene for streptococcal pyrogenic exotoxin B (SPEB), not all strains produce SPEB. Even among SPEB-producing strains, the quantity of toxin produced varies greatly from strain to strain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/44,46,48,49\">",
"     44,46,48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pyrogenic exotoxin C, like streptococcal pyrogenic exotoxin A, is bacteriophage-mediated, and expression is likewise highly variable. Mild cases of scarlet fever in England and the United States have been associated with streptococcal pyrogenic exotoxin C positive strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two new superantigens, mitogenic factor (MF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/50,51\">",
"     50,51",
"    </a>",
"    ] and streptococcal superantigen (SSA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/52\">",
"     52",
"    </a>",
"    ] have been described, but their roles in pathogenesis have not been fully investigated. One group disrupted the mf gene that encodes MF and found that the isogenic mutant did not produce DNase B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/53\">",
"     53",
"    </a>",
"    ]. The virulence of the isogenic mutant strain was equal to the parent strain in a mouse model of necrotizing fasciitis. MF was also not appreciably mitogenic in these studies compared to other superantigens. Still other investigators suggest that MF should not be labeled as a superantigen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Pheromone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two GAS strains isolated from patients with necrotizing fasciitis and myonecrosis released SilCR, a pheromone peptide; these strains degraded interleukin (IL)-8 in vitro and induced fatal necrotizing soft-tissue infection in mice characterized by decreased neutrophil recruitment to the site of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/55\">",
"     55",
"    </a>",
"    ]. In vitro, the M14 strains grown in the presence of SilCR had decreased IL-8 proteolytic activity. When bacteria and SilCR were injected together in mice, neutrophil influx occurred, bacteria were cleared, and the mice survived. The investigators postulate that this pheromone peptide represents a new virulence factor in GAS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     GENERAL PATHOGENIC MECHANISMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Anti-phagocytic properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;M-protein contributes to invasiveness through its ability to impede phagocytosis of streptococci by human PMN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ]. Conversely, type-specific antibody against the M-protein enhances phagocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ]. Following infection with a particular M-type, specific antibody confers resistance to challenge with viable GAS of that M-type [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"     3",
"    </a>",
"    ]. Investigators have shown that GAS protease cleaves the terminal portion of the M-protein, rendering the organism more susceptible to phagocytosis by normal serum but more resistant to phagocytosis in the presence of type-specific antibody [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/56\">",
"     56",
"    </a>",
"    ]. While M types 1 and 3 strains have accounted for the vast majority of isolates from cases of streptococcal toxic shock syndrome (TSS), many other M types have also been recovered from such cases, including some non-typeable strains. M types 1 and 3 are also commonly isolated from asymptomatic carriers, and patients with pharyngitis or mild scarlet fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/48,57\">",
"     48,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Mechanisms of fever induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pyrogenic exotoxins induce fever in humans and animals and also contribute to shock by lowering the threshold to exogenous endotoxin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/58\">",
"     58",
"    </a>",
"    ]. Streptococcal pyrogenic exotoxins A and B (SPEA and SPEB) induce human mononuclear cells to synthesize not only tumor necrosis factor (TNF)-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/59\">",
"     59",
"    </a>",
"    ] but also interleukin (IL)-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/60\">",
"     60",
"    </a>",
"    ] and IL-6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/60-62\">",
"     60-62",
"    </a>",
"    ], suggesting that TNF could mediate the fever, shock, and organ failure observed in patients with streptococcal TSS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/47\">",
"     47",
"    </a>",
"    ]. Streptococcal pyrogenic exotoxin C (SPEC) has been associated with mild cases of scarlet fever in the United States (author's observations) and in England [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/49\">",
"     49",
"    </a>",
"    ]. The roles of two newly described pyrogenic exotoxins, SSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/52\">",
"     52",
"    </a>",
"    ] and MF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/51\">",
"     51",
"    </a>",
"    ], in the pathogenesis of streptococcal TSS have not been elucidated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6616?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Cytokine induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is strong evidence suggesting that SPEA, SPEB, and SPEC, as well as a number of staphylococcal toxins (TSST-1, and staphylococcal enterotoxins A, B, and C) act as superantigens and stimulate T cell responses through their ability to bind to both the Class II MHC complex of antigen presenting cells and the V beta region of the T cell receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/63\">",
"     63",
"    </a>",
"    ]. The net effect is induction of T cell proliferation (via an IL-2 mechanism) with concomitant production of cytokines (eg, IL-1, TNF-alpha, TNF-beta, IL-6, interferon [IFN]-gamma) that mediate shock and tissue injury. SPEA has been demonstrated to induce both TNF-alpha and TNF-beta from mixed cultures of monocytes and lymphocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/64\">",
"     64",
"    </a>",
"    ], supporting the role of lymphokines (TNF-alpha) in shock associated with strains producing SPEA.",
"   </p>",
"   <p>",
"    A digest of M-protein type 6 can also stimulate T cell responses by this mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/65\">",
"     65",
"    </a>",
"    ]. Interestingly, quantitation of such V beta T-cell subsets in patients with acute streptococcal TSS demonstrated deletion rather than expansion, suggesting that perhaps the life-span of the expanded subset was shortened by a process of apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/66\">",
"     66",
"    </a>",
"    ]. In addition, the subsets deleted were not specific for SPEA, SPEB, SPEC, or MF suggesting that perhaps an as yet undefined superantigen may play a role in streptococcal TSS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study suggests that host genetic factors play a role in these cytokine responses to streptococcal superantigens; patients with the",
"    <span class=\"nowrap\">",
"     DRB1*1501/DQB1*0602",
"    </span>",
"    leukocyte antigen class II haplotype displayed a muted cytokine response and were less likely to develop severe systemic disease due to the organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cytokine production by less exotic mechanisms may also contribute to the genesis of shock and organ failure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peptidoglycan, lipoteichoic acid [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/68\">",
"       68",
"      </a>",
"      ] and killed organisms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/64,69\">",
"       64,69",
"      </a>",
"      ] are capable of inducing TNF-beta production by mononuclear cells in vitro [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/58,69,70\">",
"       58,69,70",
"      </a>",
"      ]. Exotoxins such as SLO are also potent inducers of TNF-beta and IL-1 beta.",
"     </li>",
"     <li>",
"      SPEB, a proteinase precursor, has the ability to cleave pre-IL-1 beta to release preformed IL-1 beta [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      SLO and SPEA together have additive effects in the induction of IL-1 beta by human mononuclear cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whatever the mechanisms, induction of cytokines in vivo is likely the cause of shock, and SLO, SPEA, SPEB, SPEC as well as cell wall components are potent inducers of TNF and IL-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/72\">",
"     72",
"    </a>",
"    ]. In addition, a cysteine protease formed from cleavage of SPEB may play an important role in pathogenesis by the release of bradykinin from endogenous kininogen and by activating metalloproteases involved in coagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Role in innate immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to the role of cytokines in invasive GAS infection, certain cytokines are involved in innate immunity against such infections. One such group is the CXC chemokines CXCL9, CXCL10, and CXCL11 as illustrated by the following observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In vitro, all the chemokines have antibacterial activity against GAS.",
"     </li>",
"     <li>",
"      Tonsillar fluid from patients with Group A streptococcal pharyngitis contains high amounts of CXCL9 and inflamed pharyngeal epithelium produce large amounts of CXCL9 in the presence of GAS. Inhibition of CXCL9 expression reduces antibacterial activity at the surface of inflamed pharyngeal cells.",
"     </li>",
"     <li>",
"      GAS of the M1 serotype secretes a protein (streptococcal inhibitor of complement) that reduces the antibacterial activity of the chemokines. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Streptococcal inhibitor of complement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Control of virulence expression factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mere presence of virulence factors, such as M-protein or pyrogenic exotoxins, may be less important in streptococcal TSS than the dynamics of their production in vivo. For example, investigators have demonstrated that approximately 40 and 75 percent of strains from patients with necrotizing fasciitis and streptococcal TSS produced SPEA or SPEB, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/72\">",
"     72",
"    </a>",
"    ]. In addition, the quantity of SPEA (but not SPEB) was higher for strains from patients with streptococcal TSS compared to patients with non-invasive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One group has proposed a regulon in GAS that controls the expression of a group of virulence genes coding for virulence factors such as M-protein and C5-peptidase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Using DNA fingerprinting, differences were shown in M-1 strains isolated from patients with invasive disease compared to M-1 strains from patients with non-invasive GAS infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/76\">",
"     76",
"    </a>",
"    ]. Such strains of GAS could acquire genetic information coding for SPEA via specific bacteriophages. Multi-locus enzyme electrophoresis demonstrates two patterns that correspond to M-1 and M-3 type organisms which produce pyrogenic exotoxin A, a finding that fits epidemiologic studies implicating these strains in invasive GAS infections in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     MECHANISMS OF TISSUE DESTRUCTION IN NECROTIZING FASCIITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid tissue destruction in GAS necrotizing",
"    <span class=\"nowrap\">",
"     fasciitis/myonecrosis",
"    </span>",
"    often necessitates extensive debridement. We have hypothesized that toxin-induced ischemia contributes to necrosis. In a rat model, toxin preparations from the invasive M-1 strain of GAS caused a rapid, dose-dependent irreversible decrease in tissue perfusion as measured by Doppler flowmetry. Videomicroscopy identified intravascular aggregates, which impeded blood flow. In vitro studies found that streptolysin O induced platelet-neutrophil aggregation and that these were mediated by upregulation of CD62P (P-selectin) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     PATHOGENIC MECHANISMS IN ACUTE RHEUMATIC FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of acute rheumatic fever involves an intimate interplay between streptococcal virulence factors and the susceptible host (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8327?source=see_link\">",
"     \"Epidemiology and pathogenesis of acute rheumatic fever\"",
"    </a>",
"    ). That T cells play an integral role was demonstrated by obtaining T-cell clones from valvular tissue of patients with rheumatic fever and showing that these clones were responsive to specific epitopes of type 5 M-protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/79\">",
"     79",
"    </a>",
"    ]. That B-lymphocytes are also critical is suggested by the cross reaction between antibodies raised against particular M-protein digests and cardiac tissue including myosin and endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/80\">",
"     80",
"    </a>",
"    ]. Interestingly, anti-myosin antibodies also react strongly to cardiac endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/81\">",
"     81",
"    </a>",
"    ]. As antibody against M-protein develops in a patient with antecedent GAS pharyngitis, antibody could fix complement. This, in turn, could damage and activate the endothelium yielding cytokines and chemokines, which attract and activate T-lymphocytes. Thus, molecular mimicry between specific epitopes on M-protein and cardiac tissue results in damage to endothelium on the heart valve mediated by specific B- and T-lymphocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     POSTSTREPTOCOCCAL GLOMERULONEPHRITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is clear that only certain strains of streptococci are capable of causing poststreptococcal glomerulonephritis. The best hypothesis at the present time is that proteins with unique antigenic determinants produced only by \"nephritogenic strains\" intercalate into the lipid bilayer of the glomerular basement membrane during the course of pharyngitis or impetigo.",
"   </p>",
"   <p>",
"    Data have implicated specific antigens, including the cysteine protease, pyrogenic exotoxin B (SPEB) and its precursor,",
"    <span class=\"nowrap\">",
"     SPEB/zymogen,",
"    </span>",
"    and glyceraldehyde-3-phosphate dehydrogenase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/82\">",
"     82",
"    </a>",
"    ] SPEB has been demonstrated by immunofluorescence microscopy in kidneys of patients with poststreptococcal glomerulonephritis, and immunization of mice with a non-catalytic mutant of SPEB causes proteinuria and histologic changes consistent with poststreptococcal glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/82-84\">",
"     82-84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Streptokinase, which has certain lipophilic regions, may be a streptococcal virulence factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/14/41193/abstract/85\">",
"     85",
"    </a>",
"    ]. Once streptokinase is membrane bound, complement is activated directly. Glomerulus-bound streptokinase interacts with circulating antistreptococcal antibodies, resulting in further complement fixation and glomerular damage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/30/35304?source=see_link\">",
"     \"Poststreptococcal glomerulonephritis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H190975995\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Group A streptococci (GAS), also known as Streptococcus pyogenes, causes a wide range of infections and complications, including pharyngitis, tonsillitis, scarlet fever, cellulitis, erysipelas, rheumatic fever, poststreptococcal glomerulonephritis, necrotizing fasciitis, myonecrosis, and lymphangitis. Over recent decades in the western world, streptococcal pharyngitis, erysipelas, and scarlet fever have become milder diseases, and the prevalence of acute rheumatic fever and poststreptococcal glomerulonephritis have reached all time lows. During the same time period, severe invasive infections such as necrotizing fasciitis and streptococcal toxic shock syndrome have increased in prevalence worldwide. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'General characteristics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Numerous different constituents and products of GAS have been identified as virulence factors. These include the capsule, the cell wall, M-proteins, M-like proteins, fibronectin binding protein (protein F), vimentin, streptococcal inhibitor of complement, opacity factor, streptolysin O, streptolysin S, pyrogenic exotoxins, and others. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Virulence factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      M-protein contributes to invasiveness through its ability to impede phagocytosis of streptococci by human PMN. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Anti-phagocytic properties'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pyrogenic exotoxins induce fever and also contribute to shock by lowering the threshold to exogenous endotoxin. Streptococcal pyrogenic exotoxins A and B (SPEA and SPEB) induce human mononuclear cells to synthesize not only tumor necrosis factor (TNF)-alpha but also interleukin (IL)-1 and IL-6, suggesting that TNF could mediate the fever, shock, and organ failure observed in patients with streptococcal toxic shock syndrome (TSS). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Mechanisms of fever induction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SPEA, SPEB, and SPEC, as well as a number of staphylococcal toxins (TSST-1, and staphylococcal enterotoxins A, B, and C) act as superantigens and stimulate T cell responses through their ability to bind to both the Class II MHC complex of antigen presenting cells and the V beta region of the T cell receptor. The net effect is induction of T cell proliferation (via an IL-2 mechanism) with concomitant production of cytokines (eg, IL-1, TNF-alpha, TNF-beta, IL-6, interferon [IFN]-gamma) that mediate shock and tissue injury. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Cytokine induction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mere presence of virulence factors, such as M-protein or pyrogenic exotoxins, may be less important in streptococcal TSS than the dynamics of their production in vivo. For example, investigators have demonstrated that approximately 40 and 75 percent of strains from patients with necrotizing fasciitis and streptococcal TSS produced SPEA or SPEB, respectively. In addition, the quantity of SPEA (but not SPEB) was higher for strains from patients with streptococcal TSS compared to patients with non-invasive disease. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Control of virulence expression factor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapid tissue destruction in GAS necrotizing",
"      <span class=\"nowrap\">",
"       fasciitis/myonecrosis",
"      </span>",
"      often necessitates extensive debridement. Toxin-induced ischemia appears to contribute to necrosis. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Mechanisms of tissue destruction in necrotizing fasciitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of acute rheumatic fever involves an intimate interplay between streptococcal virulence factors and the susceptible host. Molecular mimicry between specific epitopes on M-protein and cardiac tissue results in damage to endothelium on the heart valve mediated by specific B- and T-lymphocytes. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Pathogenic mechanisms in acute rheumatic fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Only certain strains of streptococci are capable of causing poststreptococcal glomerulonephritis. The best hypothesis is that proteins with unique antigenic determinants produced only by \"nephritogenic strains\" intercalate into the lipid bilayer of the glomerular basement membrane during the course of pharyngitis or impetigo. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Poststreptococcal glomerulonephritis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/1\">",
"      Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/2\">",
"      Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/3\">",
"      LANCEFIELD RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/4\">",
"      Stanley J, Desai M, Xerry J, et al. High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks. J Infect Dis 1996; 174:500.",
"     </a>",
"    </li>",
"    <li>",
"     Stevens DL. Streptococcus pyogenes Infections. In: Internal Medicine, 4th ed, Stein JH (Ed), Mosby, St. Louis 1994. p.2078.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/6\">",
"      Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A 1991; 88:8317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/7\">",
"      Schrager HM, Albert&iacute; S, Cywes C, et al. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest 1998; 101:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/8\">",
"      Cywes C, Wessels MR. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 2001; 414:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/9\">",
"      Gryllos I, Cywes C, Shearer MH, et al. Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol 2001; 42:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/10\">",
"      Hasty DL, Ofek I, Courtney HS, Doyle RJ. Multiple adhesins of streptococci. Infect Immun 1992; 60:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/11\">",
"      Greenblatt J, Boackle RJ, Schwab JH. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun 1978; 19:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/12\">",
"      Bisno AL. Alternate complement pathway activation by group A streptococci: role of M-protein. Infect Immun 1979; 26:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/13\">",
"      Fischetti VA. Streptococcal M protein. Sci Am 1991; 264:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/14\">",
"      Fischetti VA, Horstmann RD, Pancholi V. Location of the complement factor H binding site on streptococcal M6 protein. Infect Immun 1995; 63:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/15\">",
"      Peterson PK, Schmeling D, Cleary PP, et al. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis 1979; 139:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/16\">",
"      Dale JB, Chiang EC. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J Infect Dis 1995; 171:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/17\">",
"      Tran PO, Johnson DR, Kaplan EL. The presence of M protein in nontypeable group A streptococcal upper respiratory tract isolates from Southeast Asia. J Infect Dis 1994; 169:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/18\">",
"      Single LA, Martin DR. Clonal differences within M-types of the group A Streptococcus revealed by pulsed field gel electrophoresis. FEMS Microbiol Lett 1992; 70:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/19\">",
"      de Malmanche SA, Martin DR. Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol 1994; 183:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/20\">",
"      Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/21\">",
"      O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/22\">",
"      McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/23\">",
"      Hu MC, Walls MA, Stroop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/24\">",
"      Cohen-Poradosu R, Kasper DL. Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis 2007; 45:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/25\">",
"      Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/26\">",
"      Jaggi P, Dale JB, Chiang E, et al. Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children. Eur J Pediatr 2009; 168:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/27\">",
"      Thern A, Stenberg L, Dahlb&auml;ck B, Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol 1995; 154:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/28\">",
"      Hanski E, Caparon M. Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc Natl Acad Sci U S A 1992; 89:6172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/29\">",
"      Natanson S, Sela S, Moses AE, et al. Distribution of fibronectin-binding proteins among group A streptococci of different M types. J Infect Dis 1995; 171:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/30\">",
"      Bryant AE, Bayer CR, Huntington JD, Stevens DL. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 2006; 193:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/31\">",
"      Akesson P, Sj&ouml;holm AG, Bj&ouml;rck L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 1996; 271:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/32\">",
"      Egesten A, Eliasson M, Johansson HM, et al. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 2007; 195:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/33\">",
"      Katerov V, Lindgren PE, Totolian AA, Schal&eacute;n C. Streptococcal opacity factor: a family of bifunctional proteins with lipoproteinase and fibronectin-binding activities. Curr Microbiol 2000; 40:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/34\">",
"      Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996; 173:896.",
"     </a>",
"    </li>",
"    <li>",
"     Alouf JE, Geoffroy C. Structure activity relationships in sulfhydryl-activated toxins. In: Bacterial protein toxins, Freer JH, Jeljaszewicz J (Eds), Academic Press, London 1984. p.165.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/36\">",
"      Tweten RK. Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin. Infect Immun 1988; 56:3235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/37\">",
"      RANTZ LA, RANDALL E, RANTZ HH. Antistreptolysin O; a study of this antibody in health and in hemolytic streptococcus respiratory disease in man. Am J Med 1948; 5:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/38\">",
"      Nizet V, Beall B, Bast DJ, et al. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 2000; 68:4245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/39\">",
"      L&uuml;tticken R, L&uuml;tticken D, Johnson DR, Wannamaker LW. Application of a new method for detecting streptococcal nicotinamide adenine dinucleotide glycohydrolase to various M types of Streptoccus pyogenes. J Clin Microbiol 1976; 3:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/40\">",
"      Stevens DL, Salmi DB, McIndoo ER, Bryant AE. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome. J Infect Dis 2000; 182:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/41\">",
"      Lottenberg R, Broder CC, Boyle MD. Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun 1987; 55:1914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/42\">",
"      Edwards RJ, Taylor GW, Ferguson M, et al. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis 2005; 192:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/43\">",
"      Barsumian EL, Schlievert PM, Watson DW. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun 1978; 22:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/44\">",
"      Nida SK, Ferretti JJ. Phage influence on the synthesis of extracellular toxins in group A streptococci. Infect Immun 1982; 36:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/45\">",
"      Kline JB, Collins CM. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun 1996; 64:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/46\">",
"      Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/47\">",
"      Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/48\">",
"      K&ouml;hler W, Gerlach D, Kn&ouml;ll H. Streptococcal outbreaks and erythrogenic toxin type A. Zentralbl Bakteriol Mikrobiol Hyg A 1987; 266:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/49\">",
"      Hallas G. The production of pyrogenic exotoxins by group A streptococci. J Hyg (Lond) 1985; 95:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/50\">",
"      Iwasaki M, Igarashi H, Hinuma Y, Yutsudo T. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett 1993; 331:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/51\">",
"      Norrby-Teglund A, Newton D, Kotb M, et al. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 1994; 62:5227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/52\">",
"      Mollick JA, Miller GG, Musser JM, et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993; 92:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/53\">",
"      Sriskandan S, Unnikrishnan M, Krausz T, Cohen J. Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes. Microbiology 2000; 146 ( Pt 11):2785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/54\">",
"      Gerlach D, Schmidt KH, Fleischer B. Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF). FEMS Immunol Med Microbiol 2001; 30:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/55\">",
"      Hidalgo-Grass C, Dan-Goor M, Maly A, et al. Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Lancet 2004; 363:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/56\">",
"      Raeder R, Woischnik M, Podbielski A, Boyle MD. A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 1998; 149:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/57\">",
"      Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/58\">",
"      Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/59\">",
"      Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989; 57:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/60\">",
"      Hackett SP, Schlievert PM, Stevens DL. Cytokine production by human mononuclear cells in response to streptococcal exotoxins. Clin Res 1991; 39:189A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/61\">",
"      Norrby-Teglund A, Norgren M, Holm SE, et al. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 1994; 62:3731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/62\">",
"      M&uuml;ller-Alouf H, Alouf JE, Gerlach D, et al. Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes. Immunobiology 1992; 186:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/63\">",
"      Mollick JA, Rich RR. Characterization of a superantigen from a pathogenic strain of Streptococcus pyogenes. Clin Res 1991; 39:213A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/64\">",
"      Hackett SP, Stevens DL. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 1992; 165:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/65\">",
"      Kotb M, Ohnishi H, Majumdar G, et al. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect Immun 1993; 61:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/66\">",
"      Watanabe-Ohnishi R, Low DE, McGeer A, et al. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis 1995; 171:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/67\">",
"      Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/68\">",
"      Stevens DL, Bryant AE, Hackett SP. Gram positive shock. Curr Opin Infect Dis 1992; 5:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/69\">",
"      M&uuml;ller-Alouf H, Alouf JE, Gerlach D, et al. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun 1994; 62:4915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/70\">",
"      Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis 1993; 168:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/71\">",
"      Kapur V, Majesky MW, Li LL, et al. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A 1993; 90:7676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/72\">",
"      Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/73\">",
"      Burns EH Jr, Marciel AM, Musser JM. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun 1996; 64:4744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/74\">",
"      Simpson WJ, LaPenta D, Chen C, Cleary PP. Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol 1990; 172:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/75\">",
"      Haanes EJ, Heath DG, Cleary PP. Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol 1992; 174:4967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/76\">",
"      Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/77\">",
"      Musser JM, Hauser AR, Kim MH, et al. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A 1991; 88:2668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/78\">",
"      Bryant AE, Bayer CR, Chen RY, et al. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J Infect Dis 2005; 192:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/79\">",
"      Guilherme L, Cunha-Neto E, Coelho V, et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995; 92:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/80\">",
"      Quinn A, Ward K, Fischetti VA, et al. Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun 1998; 66:4418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/81\">",
"      Gulizia JM, Cunningham MW, McManus BM. Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol 1991; 138:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/82\">",
"      Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 2005; 68:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/83\">",
"      Cu GA, Mezzano S, Bannan JD, Zabriskie JB. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 1998; 54:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/84\">",
"      Luo YH, Kuo CF, Huang KJ, et al. Streptococcal pyrogenic exotoxin B antibodies in a mouse model of glomerulonephritis. Kidney Int 2007; 72:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/14/41193/abstract/85\">",
"      Nordstrand A, Norgren M, Ferretti JJ, Holm SE. Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun 1998; 66:315.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3167 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41193=[""].join("\n");
var outline_f40_14_41193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H190975995\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MICROBIOLOGIC CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      VIRULENCE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Capsule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cell wall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      M-proteins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Vaccine implications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Immunoglobulin binding M-like proteins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Fibronectin binding protein (protein F)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Vimentin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Streptococcal inhibitor of complement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Opacity factor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Streptolysin O",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Streptolysin S",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Deoxyribonucleases A, B, C, and D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hyaluronidase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nicotine-adenine-dinucleotidase (NADase)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Streptokinase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cell envelope proteinase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pyrogenic exotoxins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Pheromone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      GENERAL PATHOGENIC MECHANISMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Anti-phagocytic properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Mechanisms of fever induction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Cytokine induction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Role in innate immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Control of virulence expression factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      MECHANISMS OF TISSUE DESTRUCTION IN NECROTIZING FASCIITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      PATHOGENIC MECHANISMS IN ACUTE RHEUMATIC FEVER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      POSTSTREPTOCOCCAL GLOMERULONEPHRITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H190975995\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3167\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3167|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/33/15903\" title=\"picture 1\">",
"      Beta hemolysis 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8327?source=related_link\">",
"      Epidemiology and pathogenesis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6616?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33430?source=related_link\">",
"      Lipid abnormalities in nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/30/35304?source=related_link\">",
"      Poststreptococcal glomerulonephritis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_14_41194="Persistent ST segment elevation post-MI";
var content_f40_14_41194=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1260px;\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Persistent ST segment elevation post-MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 158px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The presence of an anterior wall aneurysm following an acute myocardial infarction is suspected because of persistent ST elevation in leads V2 to V4. Inverted T waves are evidence of the old infarct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41194=[""].join("\n");
var outline_f40_14_41194=null;
var title_f40_14_41195="TIMI risk index mortality MI";
var content_f40_14_41195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TIMI risk index to predict short-term mortality after acute myocardial infarction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Risk index&nbsp;",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Risk group",
"       </td>",
"       <td class=\"subtitle1\">",
"        Risk of death",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Risk of death",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        24 h",
"       </td>",
"       <td class=\"subtitle2\">",
"        In-hospital",
"       </td>",
"       <td class=\"subtitle2\">",
"        30 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &le;12.5",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;12.5 to 17.5",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;17.5 to 22.5",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"       <td>",
"        3.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;22.5 to 30",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        6.5",
"       </td>",
"       <td>",
"        7.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;30",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        6.9",
"       </td>",
"       <td>",
"        15.8",
"       </td>",
"       <td>",
"        17.4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    TIMI risk index is derived from the following formula: Heart rate in beats/min x ([age/10]squared) / systolic blood pressure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Morrow DA, Antman EM, Giugliano RP, et al. Lancet 2001; 358:1571. Copyright &copy; 2001 The Lancet, Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41195=[""].join("\n");
var outline_f40_14_41195=null;
var title_f40_14_41196="Gaucher disease classification";
var content_f40_14_41196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gaucher disease classification",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type 1",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type 2",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type 3a",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type 3b",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type 3c",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Onset",
"        </strong>",
"       </td>",
"       <td>",
"        Childhood to adult",
"       </td>",
"       <td>",
"        First year",
"       </td>",
"       <td>",
"        Childhood",
"       </td>",
"       <td>",
"        Childhood",
"       </td>",
"       <td>",
"        Childhood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Hematologic",
"        </strong>",
"       </td>",
"       <td>",
"        Anemia, thrombocytopenia",
"       </td>",
"       <td>",
"        Minimal thrombocytopenia",
"       </td>",
"       <td>",
"        Anemia",
"       </td>",
"       <td>",
"        Extensive",
"       </td>",
"       <td>",
"        Minimal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Skeletal",
"        </strong>",
"       </td>",
"       <td>",
"        Osteopenia, osteosclerosis",
"       </td>",
"       <td>",
"        Minimal",
"       </td>",
"       <td>",
"        Osteopenia, osteosclerosis",
"       </td>",
"       <td>",
"        Severe",
"       </td>",
"       <td>",
"        Minimal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Neurologic",
"        </strong>",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Generalized seizures, hypertonia, profound mental retardation, apnea",
"       </td>",
"       <td>",
"        Myoclonus, progressive dementia, ataxia, and myoclonus",
"       </td>",
"       <td>",
"        Supranuclear gaze palsy",
"       </td>",
"       <td>",
"        Supranuclear gaze palsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Other systems",
"        </strong>",
"       </td>",
"       <td>",
"        Hepatic fibrosis, pulmonary hypertension, lymphoma",
"       </td>",
"       <td>",
"        Congenital ichthyosis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Cardiac and vascular calcifications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Progression",
"        </strong>",
"       </td>",
"       <td>",
"        Slow",
"       </td>",
"       <td>",
"        Rapid",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Life span",
"        </strong>",
"       </td>",
"       <td>",
"        Shortened, may be normal",
"       </td>",
"       <td>",
"        Death before 2 years of age",
"       </td>",
"       <td>",
"        20-30 years",
"       </td>",
"       <td>",
"        Shortened",
"       </td>",
"       <td>",
"        Shortened",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mutation association",
"        </strong>",
"       </td>",
"       <td>",
"        c.1226A&gt;G (N370S allele)",
"       </td>",
"       <td>",
"        Diverse",
"       </td>",
"       <td>",
"        c.1448T&gt;C (L444P allele)",
"       </td>",
"       <td>",
"        Diverse",
"       </td>",
"       <td>",
"        c.1342G&gt;C (D409H allele)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ethnic predilection",
"        </strong>",
"       </td>",
"       <td>",
"        100 times more common in Ashkenazi Jews",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Norrbottnian region, Sweden",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Spanish?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41196=[""].join("\n");
var outline_f40_14_41196=null;
var title_f40_14_41197="Filtration equilibrium";
var content_f40_14_41197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F64698&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F64698&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Filtration equilibrium and GFR",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 218px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Depiction of the hemodynamic forces along the length of the primate glomerular capillary. The dotted line represents the hydraulic pressure in Bowman's space, Pbs. The plasma oncotic pressure is added to this so that the middle solid line represents the sum of the forces retarding filtration: Pbs + -p. The upper solid line represents the glomerular hydraulic pressure (Pgc), and the shaded area depicts the net gradient favoring filtration, Pgc - Pbs - -p, which is +13 mmHg at the afferent arteriole. As a result of ultrafiltration of protein-free fluid, -p increases until the filtration gradient is abolished and filtration ceases. This is in contrast to muscle capillaries where filtration is limited by a decline in capillary hydraulic pressure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Maddox, DA, Deen, WM, Brenner, BM, Kidney Int 1974; 5:271, and Deen, WM, Robertson, CR, Brenner, BM, Am J Physiol 1972; 223:1178. By permission from Kidney International.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41197=[""].join("\n");
var outline_f40_14_41197=null;
var title_f40_14_41198="Rx sclerosing mesenteritis";
var content_f40_14_41198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proposed treatment algorithm for sclerosing mesenteritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 414px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Akram S, Pardi DS, Schaffner JA, Smyrk TC. Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol 2007; 5:589. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41198=[""].join("\n");
var outline_f40_14_41198=null;
var title_f40_14_41199="Vocal fold nodules";
var content_f40_14_41199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vocal fold nodules",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note fairly symmetric nodular appearing lesions in the classic location at the junction of the anterior and middle thirds of the vocal folds bilaterally.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_14_41199=[""].join("\n");
var outline_f40_14_41199=null;
